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Since June of 2013, Plan B and its generics have been available over-the-counter 
without age restriction nationwide. Even so, pharmacy-based economic, physical, and 
staff-associated barriers still exist, potentially leading adolescent customers to fail to 
obtain emergency contraception (EC) in a sufficiently timely manner to prevent 
pregnancy. This study explores these pharmacy-based barriers to EC in the state of 
Kentucky focusing on comparisons of urban and non-urban pharmacies and chain and 
private pharmacies. Using a secret-shopper survey technique, the researcher called 220 
Kentucky pharmacies acting as a 15-year-old girl seeking information about EC. Among 
other findings, a logistic regression analysis revealed that private pharmacies were 97% 
less likely to carry EC compared to chain pharmacies (OR= .027; p<.001). Linear 
regression analyses found that urban pharmacies scored higher on EC knowledge (β= 
.608; p<.05) and lower on negative attitude (β= -.622; p<.01) than rural pharmacies. This 
research reveals that rural Kentucky adolescents face more barriers when seeking EC 
than urban teens. It also demonstrates that whether a pharmacy is a chain or privately-
operated is a better predictor of whether it will carry over-the-counter EC than urban or 
rural location alone. Further, it supports the argument for more pharmacy-staff training to 
effectively counsel those seeking EC and for better promotion of the EC and other family 
planning resources available through the public health system.
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Chapter 1 
INTRODUCTION TO THE STUDY 
Nearly half of all pregnancies in the United States are unintended (Guttmacher 
Institute, 2016a). Women with unintended pregnancies are more likely to have less access 
to prenatal care and to experience adverse health outcomes including low birth weight, 
developmental delays, and infant and maternal mortality (Dehlendorf, Rodriguez, Levy, 
Borrero, & Steinauer, 2010). These problems are compounded for adolescent mothers 
who often forgo educational and occupational opportunities, contributing to even further 
disparities of opportunity for their children (Dehlendorf, et al., 2010). The 2010 U.S. 
Census shows that 68% of unplanned births were paid for by public health programs, 
especially Medicaid (Guttmacher Institute, 2016a). In response to these outcomes, the 
U.S. Department of Health and Human Services’ Healthy People 2020 plan aims to lower 
unintended pregnancy by 10% by 2020 (HHS, 2014). To achieve this goal, it is necessary 
to understand factors contributing to unintended pregnancy. Among these factors is the 
availability of emergency contraception to women in general and to adolescents in 
particular. 
More than four out of five pregnancies among American females aged 19 and 
younger are unintended and nearly all (98%) pregnancies among teens younger than 15 
are reported as unintended (Finer & Zolna, 2011).  In the United States overall, the  2011 
birth rate for adolescents aged 15-17 years was 15.4  per thousand, while the rate for 
Kentucky teens aged 15-17 years was 19.6 per thousand (HHS, 2016). The U.S. teen 
birth rate fell by 49% from 1991 to 2011, while the Kentucky teen birth rate fell by only 
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37% over the same period (HHS, 2016). In 2008, 64% unintended pregnancies in 
Kentucky were described as mistimed, but 36% were described as “unwanted,” a number 
lower only than New York State at 37% (Kost, 2015). Even so, the percentage of 
unintended pregnancies in Kentucky ending in abortion was 20%, one of the lowest in the 
nation (Kost, 2015). 
 Lower educational attainment and lower socio-economic status are correlated to 
higher rates of unintended pregnancy.  In 2011, the rate of unintended pregnancy for 
women below the federal poverty level was nearly seven times higher than for women at 
200% of the federal poverty level or higher (Guttmacher Institute, 2016a). Furthermore, 
women without a high school degree had the highest rate of unintended pregnancy; this 
rate decreased with every additional year of education attained (Guttmacher Institute, 
2016a). Many women report gaps in contraceptive usage due to life-events which disrupt 
their routines. These events include moving to a new home, changes in employment or 
relationship status, or life crises. Such transitional life events are more common for 
women in lower socio-economic living conditions or with lower educational attainment 
(Frost, 2011). 
 Similarly, women of color also have higher rates of unintended pregnancy. Recent 
surveys indicate that about 69% of Black women’s pregnancies were unplanned and 54% 
of Hispanic women’s pregnancies were unplanned, compared to 40% of White women’s 
pregnancies reported as unplanned (Dehlendorf, et al., 2010).  Additionally, Hispanic 
women, especially recent immigrants with limited English language skills, have be less 
knowledge than do White women of the varieties of and proper use of available 
contraceptives (Craig, Dehlendorf, Borrero, Harper, & Rocca, 2014).   
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 The problems these at-risk population groups experience in accessing 
contraception are amplified for adolescent females who share similar demographic 
characteristics (Dehlendorf, et al., 2010). Adolescents will likely face the same barriers to 
EC access that adult women do, though these are compounded. For example, adult 
women may need to pay for contraceptives and travel to a health care provider or a 
pharmacy for contraceptives. They may also face barriers to access related to geographic 
availability or conflicting beliefs of potential providers. Adolescents seeking 
contraception without their parents’ support may encounter these barriers as well as 
greater limits on personal finance, less access to transportation, and greater opposition 
from prospective providers of contraceptive products and services (Guttmacher Institute, 
2016c). Three additional barriers are higher for teens:  confidentiality in accessing 
contraception (Guttmacher Institute, 2016b), the legal right to access contraception 
without parental consent (Guttmacher Institute, 2016c), and the lack of opportunity to 
learn about contraceptive methods (Stanger-Hall & Hall, 2011).  
 Only twelve states have laws protecting the medical privacy of adolescents 
insured as dependents (Guttmacher Institute, 2016b). Parents often learn of their minor 
and adult children’s contraceptive access in Explanation of Benefits (EOB) forms which 
disclose any services provided to any beneficiary of the insurance plan (Guttmacher 
Institute, 2016c). This can effectively eliminate insurance coverage for contraceptives for 
minors with parents opposing their access. In many states, minors cannot legally offer 
consent to services necessary to receive contraception from health care providers without 
parental approval. For example, in Connecticut, Indiana, Louisiana, Michigan, Nebraska, 
or South Dakota, a minor can only offer consent to treatment if they are married; 
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Oklahoma and New Jersey additionally allow minors to consent if they have already been 
pregnant, though not before they become pregnant (Guttmacher Institute, 2016c). 
Uniquely, in Mississippi a minor can give consent to receive contraceptive services if 
they have a letter from their clergy affirming their suitability to receive contraception 
(Guttmacher Institute, 2016c). 
Emergency Contraceptives  
 Single dose levonorgestrel products, marketed as Plan B One-Step by Teva 
Pharmaceuticals and under various generic names (Take Action, Next Choice One-Dose, 
My Way), are the most widely available and most commonly used of the three forms of 
emergency contraception in general use in the United States today (American Society for 
Emergency Contraception, 2013). Plan B One-Step costs about $48.00 while generic 
versions average $41.00 (American Society for Emergency Contraception, 2013).  Plan B 
One-Step and its generics consist of a single dose, 1.5 mg levonorgestrel tablet which is 
easy to use and rarely causes severe side-effects. The most commonly reported side-
effects are headaches, nausea and vomiting, and menstrual irregularity. Side-effects are 
generally mild and short-lived. Levonorgestrel is intended to be used within 72 hours for 
greater likelihood of preventing pregnancy. The drug is more effective the sooner after 
intercourse it is taken. Efficacy drops constantly every hour following sex, but pregnancy 
may be prevented when the dose is administered up to 120 hours after intercourse 
(Gemzell-Danielsson, Berger, and Latikumar, 2012). Unlike mifepristone, levonorgestrel 
is not an abortifacient and has no effect on a fertilized ovum (American Society for 
Emergency Contraception, 2013).  
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 Ulipristal acetate is a single dose, prescription-only alternative to levonorgestrel. 
Ulipristal is more effective as an emergency contraceptive in that its efficacy remains 
high for the full 120 hours following intercourse (Cleland et al., 2014). Like 
Levonorgestrel, ulipristal blocks fertilization of the ovum. However, ulipristal has 
significant contraindications and is inappropriate for women with renal disease, severe 
asthma, or galactose intolerance; ulipristal has also not been as thoroughly studied in 
adolescents (Koyama, Hagopian, and Linden, 2013). The fact that a prescription is 
required and use is thereby likely to be delayed prevents wider use of ulipristal. The most 
effective emergency contraceptive available is the copper intrauterine device (or IUD) 
(Cleland et al., 2014). IUDs may be simple copper or may be embedded with 
levonorgestrel. In either case, the copper ions released by the device are highly effective 
in preventing fertilization of the ovum (Cleland, Raymond, Westley, and Trussell, 2014). 
However, the necessity for the IUD to be inserted in a timely manner in a clinical setting 
prevents more frequent use as an emergency contraceptive (Cleland et al., 2014). A 
thorough description of the chemical mechanisms of action of levonorgestrel, ulipristal 
acetate, and intrauterine devices follows in Chapter 2.  
The Regulatory History of Levonorgestrel 
 As early as the mid-1960s, doctors administered high doses of estrogen to rape 
victims to prevent pregnancy. In the 1970s, the safer Yuzpe method was developed which 
combined progestin with a lower dose of estrogen. In 1998, the U.S. Food and Drug 
Administration approved the Preven Emergency Contraception Kit consisting of two pills 
(0.25 mg levonorgestrel and 0.05 mg estradiol) to be taken immediately and a second 
dose of two pills to be taken 12 hours later (Stacey, 2014). In 1999, this was further 
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improved upon with the approval of levonorgestrel-only Plan B One-Step. In February 
2001, the Center for Reproductive Rights filed a petition with the FDA to make Plan B 
available over-the-counter. In December 2003, the FDA’s Nonprescription Drugs 
committee and the Reproductive Health committee each unanimously ruled that Plan B 
was safe and effective (Stacey, 2014).  
 Even so, in May 2004, the Food and Drug Administration denied Plan B’s 
manufacturer permission to begin sales due to concerns about adolescent sexual behavior 
and health. In June of 2004, Senators Hillary Clinton and Patty Murray requested a 
General Accounting Office audit of the FDA’s decision. In July, Plan B’s manufacturer 
submitted a revised request for over-the-counter status for women age 16 or older 
(Stacey, 2014). In January 2005, in response to the FDA’s failure to rule on the over-the-
counter status of Plan B, Senators Clinton and Murray blocked President Bush’s nominee 
Lester Crawford to FDA commissioner. The senators lifted their hold after being assured 
that the FDA would rule on the matter by September 1, 2005. Instead, on August 26th, 
Commissioner Crawford postponed the decision citing a need for public comment, 
overruling the FDA’s own experts (Stacey, 2014). Under pressure from the U.S. Senate 
and the GAO, Crawford resigned after just two months as commissioner. President Bush 
nominated his own former physician Andrew von Eschenbach to head the FDA. Senators 
Clinton and Murray blocked von Eschenbach’s appointment and demanded a decision on 
Plan B. In June of 2006 the FDA formally denied the Center for Reproductive Rights’ 
petition and on August 24, 2006 announced that Plan B would only be available over-the-
counter to women 18 and older (Stacey, 2014). 
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 In March of 2009, ruling in Tummino vs. Torti, Judge Edward Korman ruled that 
the Food and Drug Administration’s denial of the Center for Reproductive Rights petition 
was “arbitrary and capricious” and ordered the FDA to allow 17 year olds over-the-
counter access to Plan B (Stacey, 2014). The FDA did so in July 2009 as part of the 
introduction of Plan B One-Step, the one pill levonorgestrel formulation. One-Step was 
made available to both women and men age 17 and older without prescription and 
production of the older multi-pill formulas ended that summer (Stacey, 2014).   
 In February 2011, Plan B’s manufacturer requested that One-Step be sold over-
the-counter without age restriction. In December, the Food and Drug Administration 
approved this request only to be immediately overruled by Kathleen Sibelius, Secretary 
of the Department of Health and Human Services. Secretary Sibelius argued that more 
research should be done before making Plan B One-Step available to young adolescents 
(Stacey, 2014). In February 2012, Judge Korman ordered the FDA to show cause for not 
making Plan B available over-the-counter. On April 5, 2013 Korman reversed the FDA’s 
rejection of the Center for Reproductive Rights’ citizen petition and ordered the FDA to 
approve levonorgestrel EC products for OTC sale without age restriction within 30 days. 
On April 30, the FDA instead ruled that Plan B One-Step would become available on 
pharmacy shelves for women age 15 and up (Stacey, 2014). On May 1, 2013 the Justice 
Department appealed Judge Korman’s order to make levonorgestrel products over-the-
counter without restriction; Korman denied the appeal. On May 13th, the Justice 
Department appealed to the Second U.S Circuit Court and was again denied. On June 20, 
2013 the Food and Drug Administration approved Plan B One-Step to be sold over-the-
counter and on store shelves to women and men without age or identification 
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requirements. On February 25, 2014 the FDA also approved generic levonorgestrel 
products to be sold over-the-counter and on store shelves without restriction, though 
packaging still stated that the product was intended for ages 17 and older (Stacey, 2014).  
Barriers to Emergency Contraception Access 
 Several barriers may prevent access to emergency contraception. While lack of 
knowledge of the existence of EC, of how to obtain EC, or of the timing limits for 
successful use of EC could limit a potential user’s access to and timely use of EC, these 
barriers are beyond the scope of this thesis. Rather, this thesis will focus on pharmacy-
based barriers to EC access.  Once a young woman has decided to seek emergency 
contraception, several factors may prevent her from obtaining EC from a pharmacy in a 
timely manner (Mackin and Clark, 2011). For the purpose of this thesis, these barriers to 
access can be characterized as economic barriers, physical barriers, and staff-introduced 
barriers such as lack of knowledge on the part of pharmacy staff and beliefs of pharmacy 
staff which may motivate them to prevent access to EC. 
Economic Barriers 
 The cost of emergency contraception presents a barrier to access for many 
women. This is especially the case for adolescents who may attempt to purchase EC 
without their parents’ permission (Guttmacher Institute, 2016c). The average cost of Plan 
B One-Step ($48) or generic levonorgestrel ($41) (American Society for Emergency 
Contraception, 2013) is generally covered by insurance, but adolescents may not have 
access to their own insurance cards or may believe that the insurance charges will be 
visible to their parents. Also, some insurers may not pay for the drug if not prescribed by 
a physician (American Society for Emergency Contraception, 2013).  One recent study 
indicated that public subsidies of oral contraceptives more than pay for themselves in 
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savings of subsidized pregnancy-related costs (Foster, Biggs, Phillips, Grindlay, and 
Grossman, 2015).  
Physical Barriers 
 Some physical barriers exist within pharmacies themselves. For example, given 
the economic barriers associated with EC, products such as Plan B may be considered 
high-theft items and therefore kept in an enclosed case or behind the pharmacist’s counter 
(American Society for Emergency Contraception, 2014). Also, many pharmacies have 
reported not carrying EC products due to low demand (Mackin and Clark, 2011). It is 
unknown to what extent not regularly carrying EC may discourage customers from 
expecting to find the product and entering the store to obtain it, thus reinforcing the 
pharmacist’s perception of a lack of demand.  On a similar note, while the pharmacy may 
only be temporarily out of stock of the product, since the efficacy of emergency 
contraceptives drops continually following the time of intercourse, any delay is a 
substantial barrier (Gemzell-Danielsson, et al., 2012). Alternatively, women may need to 
travel long distances in rural areas or via difficult public-transit routes in urban areas to 
reach a pharmacy with EC in-stock. These are also pharmacy-based physical barriers, 
though they are external to the pharmacy.  
Pharmacy Staff Lack of Knowledge 
 Researchers have found lack of knowledge on the part of pharmacists and other 
pharmacy staff to be the source of significant barriers to access of emergency 
contraception for adolescents and for women generally (Gaffaney, Stamm, Borgelt, Chau, 
Rupp, Blumhagen, and Gilroy, 2015). The foremost barrier to access for adolescents 
arising from lack of knowledge is that pharmacy staffs are often unaware of the fact that 
levonorgestrel products are now available without prescription for any individual 
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requesting them (Wilkinson, Vargas, Fahey, Suther, and Silverstein, 2015). An associated 
barrier is the improper demand for personal identification. Pharmacists and other 
pharmacy staff also are often unaware that men can legally purchase emergency 
contraception. Multiple studies have recognized the important role male partners and 
other allies can play in assisting young women in obtaining EC (e.g., Fallon, 2010; 
Schrager, Olson, Beharry, Belzer, Goldsich, Desai, and Clark, 2014). Also, staff lack of 
knowledge can present a barrier to access to the proper form of EC for a given patient. 
Studies have shown significantly decreased efficacy of levonorgestrel products in obese 
women; these patients should be directed to seek other forms of emergency contraception 
instead of or in addition to levonorgestrel (Gaffaney, et al., 2015).  
Pharmacy Staff Beliefs 
 Though economic barriers, physical barriers, and barriers arising from lack of 
knowledge among pharmacy staff are significant limiting factors to EC access, the beliefs 
of pharmacists and other pharmacy staff may present some of the barriers to access for 
adolescents seeking emergency contraceptives. Studies of the availability of EC in 
southern and western states have shown substantial barriers to access, especially in rural 
areas (e.g., Mackin and Clark, 2011; Samson, Loren, Downing, Schroeppel, Kelly, and 
Ramaswamy, 2013; Gaffaney, et at., 2015). Recent surveys of pharmacists’ attitudes have 
indicated that this lack of access is not the product of economic or physical barriers alone 
(Richman, Daley, Baldwin, Kromey, O’Rourke, and Perrin, 2012). A lack of knowledge 
on the part of pharmacy staff has been shown to be correlated to beliefs that would tend 
to indicate opposition to EC access and a desire to erect barriers to access (Wilkinson, 
Vargas, Fahey, Suther, and Silverstein, 2014).  In the absence of a proper scientific 
understanding of the chemical mechanism of levonorgestrel products, pharmacists may 
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rely on their moral beliefs concerning abortion to make decisions effecting access to EC 
by adolescent girls and women generally(Wilkinson, et.al., 2014). Despite recent and 
extensive research asserting that levonorgestrel poses no teratogenic effects and cannot 
function as an abortifacient (e.g., Glasier, 2013; Gemzell-Danielsson, 2012), multiple 
studies show pharmacists to believe that Plan B and its generics induce abortion and can 
cause birth-defects when not successfully preventing pregnancy (Richman, et al., 2012; 
Mackin and Clark, 2011).  
 In addition to doubts about levonorgestrel’s safety when used as directed, 
pharmacists have reported doubt that adolescent females can successfully understand 
directions for use of the product and that over-the-counter EC is therefore not safe for use 
by adolescents without the direction of parents or medical professionals (Richman, et al., 
2012). Also, in addition to the well documented safety of levonorgestrel products, 
multiple studies have found that adolescents are indeed capable of understanding the 
directions for proper use and of using the product properly with a negligible rate of 
complication (Raine, Ricciotti, Sokoloff, Brown, Hummel, and Harper, 2012; Manski and 
Kottke, 2015). Along with beliefs relating to supposed abortifacient and teratogenic 
properties, belief that adolescents cannot understand how to swallow a single pill 
correctly may derive much more from pharmacists’ personal beliefs than from experience 
or formal training (Wilkinson, et al., 2014).  
Need for Further Study 
 The relevant literature describes many barriers to access to emergency 
contraception and its effective use. These studies leave many unanswered questions. For 
example, many studies of EC availability in urban and rural areas, though published 
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recently, are based on data collected before the 2013 FDA regulatory change of the legal 
age for over-the-counter access. Studies of access in urban areas vs. in rural areas have 
been conducted in Iowa and Kansas, states which may not be demographically 
representative of many others. Conversely, studies of urban barriers to EC have been 
conducted in New York City, but have not, for example, included comparisons to access 
in rural areas such as upstate New York.  
 In addition to the need for more study of barriers related to emergency 
contraception, there is even greater need for study of barriers to adolescent access. The 
relevant literature demonstrates that sexually active and potentially active female 
adolescents have a severe lack of understanding of the availability of EC and face much 
greater barriers to access than do adult women (Yen, Parmar, Lin, and Ammerman, 
2015). Pharmacy based studies of adolescent access to EC have been conducted in Iowa, 
Kansas, and Wyoming but not in the American south. Among southern states, only 
Florida has been the subject of a statewide survey of pharmacists’ knowledge of and 
attitudes toward EC. To date, no studies have considered barriers to adolescent access to 
Emergency Contraception in Kentucky.   
Purpose of the Study  
 The purpose of this study is to gather previously unavailable information on the 
barriers to access of Emergency Contraception for adolescents in Kentucky. The specific 
research questions addressed by this study are as follows: 
1. Are there differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes 
based on whether a pharmacy is rural or urban? 
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2. Are there differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes 
based on whether a pharmacy is chain or privately owned? 
3. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict a pharmacy’s likelihood of 
carrying EC? 
4. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict the level of EC knowledge 
among pharmacy staff? 
5. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict the level of negative attitudes 
demonstrated by pharmacy staff? 
The study will attempt simulate the experience of an adolescent female seeking 
access to over-the-counter emergency contraception in Kentucky pharmacies. This goal 
will be achieved through a series of “secret-shopper” telephone interviews in which the 
researcher presents herself as a 15-year-old girl asking questions about the “morning after 
pill.” As the first study of its kind to be conducted in Kentucky, it will provide greatly 
needed information on the availability of over-the-counter emergency contraception in 
the state in generally and specifically for female adolescents. This research will not only 
help identify any specific areas for intervention relating to adolescent access to EC in 
Kentucky pharmacies, but it also has the potential to provide a framework for further 
study of the nature of barriers to access in this and other states. Finally, the study will 
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contribute to ongoing efforts to collect a larger body of data needed to improve current 





























Chapter 2  
 
REVIEW OF LITERATURE 
 
 The relevant literature on Emergency Contraception and over-the-counter EC 
availability includes recent work clarifying the chemical mechanism of the available 
types of EC; the ethical, social, and political factors related to the use and accessibility of 
EC; and research into the barriers to over-the-counter EC access for all women and 
specifically for adolescents. The literature also includes several studies which serve to 
highlight specific needs for further study and public health interventions.  
Varieties and Mechanisms of Emergency Contraception       
 The most recent peer-reviewed data available on the chemical mechanism and 
efficacy of available forms of Emergency Contraception, including levonorgestrel, 
ulipristal acetate, and intrauterine devices,  is summarized and discussed by Cleland and 
colleagues (2014). Levonorgestrel is the most readily available of the three primary 
emergency contraception options. Levonorgestrel is available as a single dose, 1.5 mg pill 
or less commonly as two .75 mg pills. It has been sold over-the-counter as Plan B One-
Step (one dose) since 2009 and since August 2013 has been sold without age restrictions 
(Cleland, Raymond, Westley, and Trussell, 2014). In February 2014, generic versions of 
levonorgestrel were approved to be sold under the same conditions. Prescription only 
ulipristal acetate 30 mg has been available since 2010 as Ella. Though Ella is apparently 
slightly more effective than levonorgestrel, it is not yet available over-the-counter 
(Cleland, et al., 2014).  
 Over-the-counter levonorgestrel has been found 81%-90% effective when taken 
within the recommended timeframe of up to 72 hours (Kaiser Family Foundation, 2016).  
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Researchers have found that levonorgestrel use failed to prevent 0.6% - 3.1% pregnancies 
in clinical trials, while ulipristal was effective in all but 0.9 – 2.1% of uses in clinical 
trials. Ulipristal users were, on average, 42% less likely to become pregnant than 
levonorgestrel users (Cleland, et al., 2014). Levonorgestrel has been demonstrated to 
delay luteinizing hormone surge if used before ovulation but is not effective thereafter. 
Unlike ulipristal, levonorgestrel cannot prevent follicular rupture or implantation of a 
fertilized ovum. Unlike the abortifacient drug mifepristone, levonorgestrel has no effect 
on an implanted, fertilized ovum and therefore has no abortifacient properties (Cleland, et 
al., 2014). 
 The third most common emergency contraceptive method is the copper 
intrauterine device. The IUD may be implanted up to five days following intercourse to 
prevent pregnancy, though as with all EC methods, efficacy falls rapidly over that time 
period. Copper IUD’s may or may not be impregnated with levonorgestrel; studies are 
underway to determine the additional efficacy of this combination. Without an added 
contraceptive drug, the copper ions in the IUD are believed to both interfere with sperm 
function and induce inflammatory response in the uterine tissue, preventing pregnancy 
via multiple mechanisms (Cleland, et al., 2014). This would explain the high efficacy of 
the copper IUD.  Though IUD implantation is the most effective of all EC methods 
available (greater than 99.9% effectiveness) it is also the most difficult to obtain in a 
timely and affordable manner and is thus also the least commonly used (Cleland, et al., 
2014).  An extensive review of the current understanding of the chemical mechanisms of 
these three forms of emergency contraception and also of mifepristone is available in 
Gemzell-Danielsson, Berger, and Latikumar (2012).   
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 Researchers have found higher body weight to reduce the efficacy of oral 
emergency contraceptives. Levonorgestrel may be much less effective for women with 
BMIs above 26. Drugs which reduce the effectiveness of other oral contraceptives are 
believed to lower the effectiveness of levonorgestrel, though to what extent, given the 
high dose administered in EC formulations, is unknown (Cleland, et al., 2014). Both body 
weight and drug interactions which apparently lower efficacy need further study.  
 Despite these limitations, side effects are relatively mild and pass quickly in most 
cases. The most common side effects reported were nausea and menstrual irregularity. No 
serious complications or deaths have been linked to oral emergency contraceptive use and 
levonorgestrel poses no known serious health risks to women or teratogenic risks to 
children born in case of failure of the drug to prevent pregnancy. Oral EC is, in fact, 
known to be safer than IUD insertion for women with pelvic inflammatory disease, 
cervicitis, chlamydia, or active gonorrhea (Cleland, et al., 2014).  
 Koyama, Hagopian, and Linden (2013) have presented further possible 
contraindications for ulipristal and thus reaffirmed the greater relative safety of 
levonorgestrel. Among these are glucocorticoids, which are used to treat asthma and 
which may be rendered ineffective by ulipristal. The authors also list several drugs which 
may decrease the effectiveness of ulipristal, including barbiturates, carbamazepine, 
oxcarbazepine, phenytoin, rifampin, St. John’s Wort, and several anti-retrovirals 
(Koyama, Hagopian, and Linden, 2013).   
 Glasier (2013) focuses on clinical outcomes of levonorgestrel and other 
emergency contraceptive methods. This meta-analysis found that levonorgestrel, like 
other progestogens, is exceptionally safe with an extremely low risk of adverse effects. 
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The author found no evidence of higher risk of ectopic pregnancy or birth defects due to 
levonorgestrel use and no evidence of adverse developmental effects for adolescents 
using the drug.  The study also showed that side effects such as dysmenorrhea, fatigue, 
abdominal pain, nausea, and headache are no greater for levonorgestrel users than for 
participants in control groups taking no medications who were asked to keep daily diaries 
of such minor complaints (Glasier, 2013).  
Ethical, Social and Political Considerations 
Lewis and Sullivan (2012) writing in Ethics and Medicine considered the ethical 
arguments for health care providers and pharmacy staff to refuse to provide emergency 
contraceptives such as levonorgestrel which have been specifically shown to have no 
abortifacient properties. Having reviewed all available studies on levonorgestrel’s 
chemical properties and mechanism, they found that moral claims based on belief that EC 
functions as an abortifacient are fully baseless and untenable. They argue that such a 
refusal of care has no basis in medical ethics (Lewis and Sullivan, 2012).   
 Price (2011) considered the role of sexual ethics and personal mores in the 
construction of public policy concerning access to emergency contraception for 
adolescents and found that desires to maintain parental authority and expectations of 
sexual “purity” for teenage girls have been the primary causes for the subordination of 
health policy to personal ethics.  The author identified culturally and religiously based 
fears and anxieties as giving rise to extreme discomfort with the existence of adolescent 
sexuality. Parents tend to explain that providing access to contraceptives implies adult 
permission for sexual activity. The author advocated acceptance of the fact of adolescent 
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sexuality and the formulation of public policy on that basis rather than attempts to placate 
parents’ discomfort with teen sexual activity (Price, 2011).  
 A similar argument is made by Thompson and colleagues (2013). The authors 
discuss the past regulation of emergency contraception on the basis of political influences 
and social concerns rather than medical fact and public health data. Their argument, 
however, focuses more on the overwhelming scientific research in favor of permitting 
unrestricted access to oral emergency contraceptives. The authors note that a 2009 study 
found that fewer than one in ten thousand EC users were younger than age 13. They also 
review data specifically on the safety of Plan B One-Step for adolescents aged 13-16 and 
find age restrictions to be medically unjustifiable and an unnecessary barrier to access 
(Thompson, Raine, Foster, Speidel, Darney, Brindis, and Harper, 2013).   
 The authors of the official position statement of the Women’s Health Practice and 
Research Network of The American College of Clinical Pharmacy argue that pharmacists 
have a duty to advocate for the patients’ right to access emergency contraception and to 
facilitate access in their own pharmacies and beyond by ensuring timely access, lowering 
barriers to access, and educating their patients on proper emergency contraceptive use 
(Rafie, McIntosh, Gardner, Gawronski, Karaoui, Koepf, and Patel-Shori, 2013). 
Barriers: Economic and Physical 
 No extensive analysis of the role of cost as an economic barrier to access to 
emergency contraception has yet been conducted. Though not specifically on emergency 
contraception, Foster and colleagues (2015) argue that cost may be the most important 
barrier to access to oral contraceptives in general. Econometric analysis correlating 
income level to likelihood of use of oral contraceptives in general led the researchers to 
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determine that, assuming no additional cost to the consumer, up to an additional 21% of 
women might use oral contraceptives. Depending on other factors, this would result in a 
7% to 25% decrease in unwanted pregnancies. The authors find that providing low or no 
cost contraceptive coverage to low income women would radically lower healthcare costs 
(Foster, Biggs, Phillips, Grindlay, and Grossman, 2015). A similar argument would likely 
hold true for EC subsidization.  
 Studies of access to emergency contraception in urban areas have produced 
somewhat contradictory results. Bell, Camacho, and Velasquez (2014) intended to study 
availability of emergency contraception to men posing as mystery shoppers in various 
New York City neighborhoods. The study found the men were able to access EC 80% of 
the time and determined that economic barriers were the most significant impediments to 
access. The authors noted that pharmacies in lower socio-economic status neighborhoods 
had more restrictive hours and that the men had to travel to higher socio-economic status 
neighborhoods to access EC during those times, presenting a barrier to access. Legare 
and colleagues (2012) found no significant same-day availability of EC: 94 % available 
in East Harlem pharmacies and 93% on the Upper East Side. Given that average cost was 
$45.16 in East Harlem and $51.64 in Upper East Side pharmacies, the authors concluded 
these prices to be relatively low barriers to access (Legare, Bakshi, Keyhani, and Howell, 
2012). These studies indicate that in urban areas, if a given pharmacy does not have 
same-day availability, a nearby pharmacy likely will. In urban areas, therefore, economic 
barriers may pose the greater relative barrier to access.  
 Other economic and physical barriers to access are likely in rural areas. Mackin 
and Clark (2011) studied availability of emergency contraception in Iowa pharmacies 
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before and after the 2006 FDA decision to make Plan B One-Step available without 
prescription. Though the number of pharmacies carrying Plan B increased from 57.8% to 
70% following the change, the number of pharmacies reporting lack of demand as their 
reason for not carrying EC remained consistent: 67.5% before and 66.7 % after. This 
limitation to access is likely self-perpetuating. After moral objections, low demand was 
the primary reason cited by pharmacists who chose to not carry EC. Where EC is not 
regularly available, shoppers may be discouraged from requesting it, reinforcing the 
perception of lack of demand (Mackin and Clark, 2011).   
 Samson and colleagues (2013) conducted a survey designed to ascertain 
differences in availability at urban and rural pharmacies in Kansas. Researchers 
telephoned 201 pharmacies selected by random number generator. One hundred eighty-
six pharmacists agreed to be interviewed. Pharmacists were asked if they carried EC and 
if it was currently in stock or available in 24 hours. Eighty-five percent of urban 
pharmacies could dispense EC within 24 hours while only 75% of rural pharmacies 
could. However, urban pharmacies were almost twice as likely to have EC in stock at the 
time of request. Further, urban pharmacies which were out of stock of EC were often 
corporate chain pharmacies which could direct patients to another branch nearby. The 
authors found that rural, independent pharmacies were least likely to carry EC, to have 
EC in current stock, or to be able to dispense EC within 24 hours (Samson, Loren, 
Downing, Schroeppel, Kelly, and Ramaswamy, 2013).   
 Other researchers conducted a similar study in which secret shoppers called each 
of the 66 retail pharmacies in Wyoming. Gaffaney and colleagues (2015) asked a series 
of questions about EC location in the store, age and ID requirements, weight 
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appropriateness, and if the product was in stock. Since the survey was conducted after the 
June 2013 approval for OTC access without age restriction, complete accessibility was 
defined as in stock, on the shelf, and accessible without age or ID requirements. By these 
standards, only 10 of 63 pharmacies from which information was successfully gathered 
offered complete accessibility. Fifty-six pharmacies reported that emergency 
contraception was in stock. Thirty-six of the 63 pharmacies improperly imposed an ID 
requirement (Gaffaney, Stamm, Borgelt, Chau, Rupp, Blumhagen, and Gilroy, 2015). 
Given the recent change in regulatory status of EC products, it is difficult to determine 
whether and to what extent confusion or intent to avoid selling EC played a role in 
inaccessibility.  
 Many researchers have found that women in rural communities face significant 
physical barriers to EC access in the form of absence from store shelves and the added 
economic barrier of travel to another community to find the product in a timely manner 
(e.g., Mackin and Clark, 2011; Samson et al., 2013; and Gaffaney et al., 2015). In 
recognition of the fact of lower rural accessibility, Kelleher (2010) discusses the viability 
of a so-called moderate solution to pharmacist refusal to provide EC. The author 
examines the reasonability of allowing urban pharmacists to decline to provide EC given 
the supposed greater availability of EC in a given urban area. Kelleher rejected an urban-
only pharmacy opt-out option, arguing that many of the same factors limiting access in 
rural communities may apply in low-income urban neighborhoods. Women in low socio-
economic status neighborhoods may lack the money or free time to travel to other 
neighborhoods and to require them to so do would represent an unjustifiable barrier to 
access (Kelleher, 2010).   
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Barriers: Pharmacy Staff’s Lack of Knowledge 
 In an extensive study of emergency contraception access conducted in five 
American cities, Wilkinson and colleagues (2012) used secret shoppers to contact 943 
pharmacies and had them present themselves as either as 17-year-olds requesting 
emergency contraception or as physicians requesting EC for their 17-year-old patients. 
Nineteen percent of pharmacies told “adolescent” callers it would be impossible for the 
pharmacy to dispense EC to them under any circumstances. Only 3% of physicians were 
told this. Only 57% of adolescents and 61% of physicians were told the correct age (at 
the time of the survey) for access to EC without prescription. That physicians were told 
incorrect data at a frequency near that for adolescents arguably indicates lack of 
knowledge more than intent to deceive (Wilkinson, Fahey, Shields, Suther, Cabral, and 
Silverstein, 2012). In a follow-up article to the same study, Wilkinson and other 
colleagues note that pharmacy staff often displayed confusion over EC regulations, 
imposed improper barriers to access, and were apparently unaware of their obligation to 
maintain confidentiality even for minor patients (Wilkinson, Vargas, Fahey, Suther, and 
Silverstein, 2015).  
 Researchers Young, Griffin, and Vest (2013) found that pharmacy students 
nearing completion of their degree are aware of their lack of knowledge of emergency 
contraception and that schools of pharmacy may not be adequately preparing new 
pharmacists for their responsibility to adolescent EC users.  In a teaching exercise 
conducted at Midwestern University Chicago College of Pharmacy, two hundred third-
year pharmacy students observed skits and were partnered with classmates for practice in 
emergency contraceptive counseling. Prior to the workshop, only 25% of the pharmacy 
students reported confidence in counseling patients on emergency contraceptive use. 
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Following participation in the exercise, 58.8% reported confidence in their counseling 
ability. The most commonly self-reported barrier to self-efficacy in counseling was lack 
of knowledge (Young, Griffin, and Vest, 2013).  
 Even in locales where most pharmacies were helpful and actively sought to make 
emergency contraception available, lack of knowledge remains a barrier to access for 
adolescents.   Orr and colleagues (2015) describe data from telephone interactions in 
which female researchers posing as patients seeking EC called Rhode Island pharmacies 
in the spring of 2009 and again in spring of 2012. Ninety percent of pharmacies stocked 
EC each year. Notably, however, the number of pharmacies which provided the correct 
minimum legal age for purchase (prior to removal of that restriction in 2013) fell from 
67% to 53%. The authors describe overall access to EC in Rhode Island as “very good” 
and determined the misunderstanding of the legal age for over-the-counter access to 
emergency contraception appears to be an honest mistake on the part of pharmacy staff 
(Orr, Lemay, Wojtusik, Opydo-Rossoni, and Cohen, 2015).  
 After age requirements, another common misunderstanding on the part of 
pharmacy staff is the belief that levonorgestrel and ulipristal act as abortifacients in a 
manner similar to mifepristone. Though ample literature to the contrary as discussed 
above is available, surveys of practicing pharmacists and other pharmacy staff find this 
belief to be relatively common. Mackin and Clark’s (2011) study of Iowa pharmacies 
before and after the 2006 FDA approval of over-the-counter access with age restrictions 
found that following that change, 38% of Iowa pharmacists still reported that they 
understood EC to function as an abortifacient.  
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 Richman and colleagues (2012) considered responses to a 2008 survey of 1,264 
randomly selected pharmacists registered with the Florida Board of Pharmacy. Though 
only 22% of selected pharmacists returned their unsolicited questionnaires and it is 
improper to consider this sample representative of Florida pharmacists overall, their 
responses nonetheless indicate the presence of significant barriers to EC access due to 
lack of knowledge. Forty-six percent of respondents answered in the affirmative that EC 
does induce abortion. Fifty-six percent of pharmacists responding reported that EC causes 
birth defects, again, contrary to the overwhelming evidence to the contrary. Only 22% of 
respondents correctly answered that EC could be purchased prior to need (Richman, 
Daley, Baldwin, Kromey, O’Rourke, and Perrin, 2012).  
 Gaffaney and colleagues (2015) reported that in their survey of Wyoming 
pharmacies conducted following the June 2013 removal of age and, therefore, 
identification requirements, 36 of the 63 pharmacies surveyed nonetheless improperly 
imposed an ID requirement. The authors also found that pharmacy staff at only 21 of the 
63 pharmacies accurately communicated that emergency contraceptives are less effective 
in obese women (Gaffaney, Stamm, Borgelt, Chau, Rupp, Blumhagen & Gilroy, 2015).  
 Sixty-one percent of Florida pharmacists surveyed by Richman and colleagues 
(2012) expressed general “discomfort” with dispensing EC to adolescents. While 
personal beliefs likely account for an indeterminable portion of this discomfort, Mackin 
and colleagues (2011) found that while prior to 2006 43.8% of Iowa pharmacists 
understood EC to be safe for adolescents, that percentage fell to 27.9% following the 
change to over-the-counter status for Plan B. The thing that changed in that time was the 
ability of teens to purchase Plan B without medical examination or extensive advising as 
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to the proper use of the drug (Mackin, et al., 2011). Many pharmacists are apparently 
unaware of or doubt the studies showing the high degree of safety for levonorgestrel 
users or they doubt adolescents’ ability to understand the drug’s instructions and use it 
properly.  
 Two recent studies have shown such concerns to be unfounded and the source of 
unnecessary barriers to access. Manski and Kottke (2015) conducted a study of teen 
attitudes to EC as gathered from a survey conducted via advertisements on Facebook. 
Three hundred forty-eight females aged 14-17 years responded. Along with questions 
concerning their sexual activity and attitudes, respondents participated in a brief tutorial 
on key concepts necessary to understand for proper use of levonorgestrel. On average, 
participants were able to understand 7.1 of 8 concepts needed for proper EC use without 
further instruction (Manski and Kottke, 2015). Given that it would be reasonable to 
expect that many adolescent or adult users might not achieve a perfect score on such a 
quiz even if instructed by a doctor or pharmacist on proper use, it seems clear that the 
great majority of adolescents are able to understand how to take the single dose in a 
timely manner as instructed.  
  Raine and colleagues (2012) also examined the ability of adolescent females to 
safely and properly use EC. The study considered, adolescents aged 11-17 who requested 
EC at reproductive health centers in five U.S. cities were asked to read the product label 
and describe to healthcare providers how to use the product. The EC product was then 
dispensed to those patients who accurately understood the label instructions. Those 
patients were contacted one, four, and eight weeks later for follow-up interviews. Over 
nine in ten patients (91.5%) were able to understand the label and choose appropriately 
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whether to use the EC product or not. About ninety-three percent (92.9%) of participants 
used the product according to label instructions. Only 2.3% of participants who used the 
product became pregnant. No participants reported adverse side-effects (Raine, Ricciotti, 
Sokoloff, Brown, Hummel, and Harper, 2012).  Again, these results would indicate that 
few proposed restrictions on use by adolescents are medically justifiable. 
Barriers:  Pharmacy Staff’s Beliefs 
 As described above, the personal beliefs of parents and lawmakers have been 
primary factors in shaping public health policy on adolescent access to emergency 
contraception (Price, 2011; Thompson, et al., 2013). The beliefs of pharmacists and other 
pharmacy staff also play a highly significant role in the imposition of barriers to EC 
access. Many of the same studies that examine the role of lack of knowledge also 
contribute to a greater understanding of the role of the beliefs of pharmacy staff on 
adolescent access to emergency contraception. It appears that lack of scientific 
knowledge on EC often correlates to a reliance on personal belief on the part of pharmacy 
staff in making decisions concerning the dispensing of emergency contraception. For 
example, Wilkinson and colleagues (2014) found that the same pharmacy staffs that 
showed confusion and uncertainty as to emergency contraception regulations also 
resorted to ethical terms when describing their own pharmacy’s policies on EC 
availability. Despite extensive evidence of the absence of abortifacient properties cited 
above, many pharmacists and other pharmacy workers believe use of or dispensing of 
levonorgestrel emergency contraceptives to be a form of abortion and therefore morally 
objectionable (Mackin and Clark, 2011; Richard, Kinzey, and Masters, 2015). Many 
pharmacists also persist in the belief, shown to be false by Raine and colleagues (2012) 
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and by Manski and Kottke (2015) that levonorgestrel is unsafe for adolescents without 
medical and adult supervision.  
 As discussed above, Mackin and Clark (2011) found that 38% of pharmacists in 
Iowa at the time they were surveyed believed Plan B to function as an abortifacient. 
Likewise, Richman, et al. (2012) found that 46% of pharmacists responding to the survey 
believed Plan B induces abortion. In both cases, it is difficult to know where 
misunderstanding of chemical mechanism of levonorgestrel ends and personal beliefs 
concerning abortion begin. However, neither study asked pharmacists both what they 
understood about the chemical function of emergency contraception and their personal 
beliefs concerning abortion.  
 An extensive recent study of pharmacist beliefs concerning the dispensing of 
hormonal contraceptives in general was conducted in the rural town of Winchester, 
Virginia. Richard, Kinzey, and Masters (2015) sent surveys to each of the town’s 52 
pharmacists, who work in 32 pharmacies, in March of 2011.  The survey had a 63% 
response rate. The survey questioned attitudes toward hormonal contraceptives generally, 
but not EC specifically. Fifty-four percent of responding pharmacists opposed 
prescription of hormonal contraception by pharmacists. Ninety-five percent opposed 
over-the-counter access to any hormonal contraceptives and 71% did not even support 
behind-the-counter access. Eighty percent of pharmacists responding doubted their 
patients’ ability to self-screen for contraindications (Richard, Kinzey, and Masters, 2015). 
This opposition on the part of Winchester, Virginia’s pharmacists is in extreme contrast 
to the relative ease of access observed by Orr and colleagues (2015) in their survey of 
Rhode Island pharmacies or by Legare and colleagues (2012) in their study of New York 
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City pharmacies. These findings strongly indicate that in many rural communities there 
may be very little advocacy for expanded access to contraceptives of any kind on the part 
of pharmacists, let alone support for greater access to emergency contraceptives. 
Need for Further Study and Public Health Interventions 
 Writing prior to the 2013 expansion of availability, Devine (2012) seeks to 
explain the failure of EC to lower the rate of unintended pregnancy despite prescription 
availability for three decades and over-the-counter availability since 2006. The author 
attributes this lack of effectiveness to a combination of lack of awareness of the nature of 
EC and its over-the-counter status, the incorrect belief that EC is an abortifacient, privacy 
concerns, and concerns over adverse health effects. Further study will be necessary to 
determine if the 2013 expansion of access contributed to greater utilization of EC. 
 Baird and colleagues (2015) also discuss the failure of greater EC availability to 
lower the rate of unintended pregnancy. The authors note that all approved forms of 
emergency contraceptives are less effective than regular use of any other physical or 
hormonal contraceptives available. Along with the need for greater public awareness of 
and access to emergency contraception, the authors advocate public health interventions 
aimed at ensuring that women who use EC will transition successfully afterwards to 
regular, more effective birth control methods and to prevent overreliance on EC as a birth 
control method (Baird, Cameron, Evers, Gemzell-Danielsson, Glasier, Moreau, and 
Volpe, 2015). 
 Melton, Stanford, and Dewitt (2012) specifically studied the potential problem of 
overreliance on EC as a primary form of contraceptive. The authors are concerned that 
many women in a Utah survey of emergency contraception use reported using EC more 
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than once in the previous year. Echoing other researchers’ concerns that women should 
be encouraged to begin a regular contraceptive method following EC use, the authors 
warn against the alternative of accidentally instilling an overly high estimation of the 
efficacy of EC. Levonorgestrel pills were believed to be about 77% effective as of the 
most recent data available at the time of the survey. Of the women surveyed, 58% 
believed Plan B to be 90% effective and 16% reported belief that it is nearly 100% 
effective. The authors assert that women who repeatedly use EC successfully likely 
overestimate its effectiveness (Melton, Stanford, and Dewitt, 2012). Efforts to increase 
access should be wary of inducing dependence on EC as more than a backup method of 
contraception.  
  Researchers have also studied the possibility that increased availability of EC in 
pharmacies may result in fewer sexual assault victims seeing help in emergency rooms. 
Gross, Lafortune, and Low (2014) speculate that this would lead to a lower rate of 
reporting of sexual assaults and prevent timely collection of physical evidence of assault. 
The authors do not assert that they have conclusively proven this hypothesis and research 
is ongoing, but they highlight the need for pharmacists and public health professionals to 
consider this possibility when implementing any plan to increase accessibility of EC.  
 Durrance (2013), writing in Economic Inquiry considered a possible correlation 
between trends in sexually transmitted infections and the increased access to EC.  Acting 
to increase access to emergency contraception many years before over-the-counter status 
was approved by the FDA in 2006, Washington State officials allowed pharmacists to 
begin prescribing EC in 1998. Following that change, rates of gonorrhea infections both 
in women and in men rose in significant correlation to the increase in EC availability at 
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the county level. The author has been unable to discount this correlation with falsification 
tests. It may be that pharmacies were simply more likely to provide greater EC access in 
counties that were already trending toward more unsafe sexual contact in response to that 
need; an upward trend in unsafe sex would explain both greater need or EC and a raise in 
STD infections. In any case, any such trend requires explanation.  
 In a recent broader study, Atkins and Bradford (2015) also considered the 
possibility that greater access to emergency contraception could lead to greater sexual 
risk taking by women. Their data set was collected for the National Longitudinal Survey 
of Youth from October 1999 through November 2009 on 3,786 women age 18 and over. 
This provided data from years before and after the 2006 FDA decision to allow states to 
permit pharmacies to provide EC over-the-counter, without prescription. The data set also 
included women in states with and without over-the-counter EC.  The authors were able 
to consider variables including frequency of sexual activity, number of partners, condom 
use, etc. The researchers found no relationship between the 2006 national policy change 
and probability of sexual activity, likelihood of unprotected sexual activity, or number of 
sexual partnerships (Atkins and Bradford, 2015). Women in the states which chose to 
make EC available without prescription did report greater likelihood of unprotected sex, 
though this may correlate to the variance in sexual mores by state or with the passage of 
time rather than indicate a causal relationship to the change in EC availability.  
 Several researchers have recognized and studied the role of sexual partners and 
other allies in accessing emergency contraception. Bell, Camacho, and Velásquez, (2014) 
sent male mystery shoppers into pharmacies in three New York City neighborhoods to 
request EC. While almost three-quarters of pharmacies (73.3%) were considered by the 
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authors to have presented some barriers to EC access, the most common barriers to 
access were found to be limited hours in lower socio-economic status neighborhoods and 
higher cost in higher socio-economic status neighborhoods. Despite various barriers, the 
male mystery shoppers in the study were able to access EC 80% of the time (Bell, 
Camacho, and Velásquez, 2014). 
 Schrager and colleagues (2014) reported the findings of surveys of 198 new 
patients at two Los Angeles primary care clinics on their past use of, knowledge of, and 
attitudes toward emergency contraception. Only about half of women and one third of 
men knew EC was available without prescription. Only 24% knew that males could 
purchase EC for partners (Schrager, Olson, Beharry, Belzer, Goldsich, Desai, and Clark, 
2014). These studies indicate that greater public health education efforts aimed at men 
and at informing women that their male partners can help them obtain EC in a timely 
manner. 
 Through a qualitative study of the experiences of adolescent females in accessing 
EC, Fallon (2010) explores how teens have relied on peers to deal with shame and 
barriers to access of EC. The girls interviewed described their efforts in helping each 
other to obtain EC confidentially and understand how to use the product properly. Fallon 
(2010) finds that teens can assume supporting roles and shed labels associated with 
underage sexual activity in favor of self-efficacy in the face of opposition to their access 
to contraceptives. These findings have important implications for efforts to educate 
minors about the use of and access to EC. While adolescent peers may not be ideal 
reproductive care advocates, health professionals should realize that teens will likely turn 
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to their peers for support.  Public health education interventions should be designed with 
such considerations in mind.  
 Several studies have found evidence of a general lack of knowledge as to the 
nature of and availability of emergency contraception among female adolescents, women 
in general, and the public overall.  Yen and colleagues (2015) reported the results of 
anonymous surveys of 439 uninsured young people aged 13 to 25 using the services of 
mobile primary care provider in the San Francisco, California Bay Area from 2010 to 
2012. The mean age of the respondents was 17.8 years and 66% of respondents were 
women. Eighty-six percent of young women reported having heard of EC, but most 
respondents had many misunderstandings about the nature of EC. Forty percent of 
respondents incorrectly believed emergency contraception induced abortion. Forty-four 
percent incorrectly believed EC had to be taken within 24 hours of intercourse. Only 40% 
of the young women were aware that EC was available without prescription. 
Additionally, 72% did not know that males could purchase EC for their partners (Yen, 
Parmar, Lin, and Ammerman, 2015). In a similar study of 226 young females aged 14-19 
years old presenting for treatment at two urban emergency departments Mollen and 
colleagues (2013) likewise found significant lack of knowledge of the safety and 
availability of EC. The majority of the teens surveyed expressed concern about long-term 
(78% of respondents) and short-term (86%) adverse side-effects. Forty-five percent 
believed they needed a prescription and doubted they would be able to get one quickly 
(Mollen, Miller, Hayes, and Barg, 2013).  
 The above information demonstrates that a need exists for public health 
interventions to educate young women, pharmacy staff, and indeed the general public 
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about the use, efficacy, and availability of emergency contraceptives. Several 
interventions have in fact been completed in pharmacy settings which have been shown 
to significantly increase patients’ and pharmacy staffs’ knowledge and reduce barriers to 
EC access. Ragland, Payakachat, and Stafford (2015) describe the results of an 
intervention conducted in a retail pharmacy setting over the course of two months in 
2012. Pharmacy students counseled female participants for ten minutes on the basics of 
use of and access to EC. Participants were tested before counseling to establish what the 
women already knew and were tested again following counseling. The women were also 
contacted by telephone 1 to 3 months later for a follow-up test. Tests immediately after 
counseling showed significant increase in understanding of EC. The follow-up tests also 
showed significantly higher scores (Ragland, Payakachat, and Stafford, 2015). These 
results show that minimal time spent educating patients in a pharmacy setting can lead to 
an immediate and long-lasting increase in understanding of EC related information. 
Batra, Aquilino, and Farris (2015) evaluated pharmacy staff survey results following a 
two year intervention designed to reduce unplanned pregnancy in women aged 18 to 30 
in 12 Iowa counties. The staff had all participated in online education and campaign 
materials such as posters and brochures were available in the 55 pharmacies included in 
the intervention. Though the study did not focus on emergency contraception, the authors 
significantly found that 90% of participating staff found discussing contraceptive use 
with patients easy after the intervention and expressed a desire to prioritize the topic 
(Batra, Aquilino, and Farris, 2015).  That the Iowa pharmacy staff became more open to 
discussing contraception in general does not necessarily imply an increased desire to 
provide EC. This emphasizes the need for the integration of EC specific education into 
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any intervention designed to improve pharmacy staff dialog with women on 
contraceptives in general.  
 Finally, Young, Griffin, and Vest (2013) described the results of a teaching 
exercise conducted at Midwestern University Chicago College of Pharmacy. Two 
hundred third-year pharmacy students observed skits and were partnered with classmates 
for practice in emergency contraceptive counseling. Prior to the workshop, only 25% of 
the pharmacy students reported confidence in counseling patients on emergency 
contraceptive use. Following participation in the exercise, 58.8% reported confidence in 
their counseling ability. The most commonly self-reported barrier to self-efficacy in 
counseling was lack of knowledge (Young, Griffin, and Vest, 2013). The results of this 
workshop indicate that significant gains in EC counseling skills pharmacists can be 
achieved with minimal additional instruction and practice. Though the practice partners 
were adult pharmacy students, the workshop results indicate that education and practice 
in counseling minors could produce equal or greater increases in pharmacists’ knowledge 
and comfort with counseling adolescents on EC use. 
 The relevant literature affirms the safety of levonorgestrel EC products and 
describes the social rather than scientific basis of opposition to greater access to 
Emergency Contraception and the resulting barriers. Much of the relevant literature is 
designed to explore and understand those barriers, but this research is limited in scope. 
Specifically, the only studies conducted in the southern United States have been surveys 
of pharmacists in Florida and in Winchester, Virginia. While more extensive statewide 
studies have been conducted in Iowa, Kansas, Rhode Island, and Wyoming, barriers to 
EC in these states may not be representative of barriers to EC access elsewhere. These 
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studies do, however, demonstrate the feasibility of collecting valuable data on barriers to 
EC, specifically via “secret shopper” interviews. The opportunity to expand the literature 
to include a study of over-the-counter EC access in Kentucky and to improve upon both 
the selection of questions to be asked and the analysis of the data collected provides a 


























Chapter 3  
 
 METHODOLOGY  
 
This study simulated the experience of an adolescent female seeking access to 
over-the-counter emergency birth control in Kentucky pharmacies. A cross-sectional, 
mixed-methods study was developed to gather descriptive information and data that can 
yield answers to the following research questions: 
1. Are there differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes 
based on whether a pharmacy is rural or urban? 
2. Are there differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes 
based on whether a pharmacy is chain or privately owned? 
3. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict a pharmacy’s likelihood of 
carrying EC? 
4. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict the level of EC knowledge 
among pharmacy staff? 
5. Do factors such as whether a pharmacy is chain or privately operated 
or whether it is urban or rural predict the level of negative attitudes 
demonstrated by pharmacy staff? 
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Study Design and Justification 
Data collection began in July 2016, after receiving approval from Western 
Kentucky University’s Institutional Review Board. The researcher telephoned selected 
Kentucky pharmacies in the sample areas posing as a potential customer, known as a 
“secret shopper” study when used in market research. The caller presented herself as a 
15-year-old female who had unprotected sex two days prior to the phone call and needed 
more information on the product. The age was chosen based on the 2013 change to the 
law that allows anyone to purchase EC over the counter without a prescription rather than 
restricting purchase to people aged 17 years and older. The caller followed a semi-
structured script designed to assess pharmacy staff knowledge of levonorgestrel 
(effectiveness, function, etc.), knowledge of the legal status of levonorgestrel, and 
financial and physical accessibility.  
Although the “secret shopper” design involved a level of deception, this research 
approach has been used successfully in previous studies assessing adolescent access to 
over-the-counter emergency contraception. In an extensive study of emergency 
contraceptive access conducted in five American cities, Wilkinson, Fahey, Shields, 
Suther, Cabral, and Silverstein (2012) used secret shoppers to contact 943 pharmacies by 
phone and had them pose either as 17-year-olds requesting emergency contraception or as 
physicians requesting EC for their 17-year-old patients. In another study, Orr, Lemay, 
Wojtusik, Opydo-Rossoni, and Cohen (2015) collected aggregate data from telephone 
interactions in which female researchers posing as patients seeking EC called Rhode 
Island pharmacies in the spring of 2009 and again in spring of 2012. In order to 
determine if a girl’s sexual partner or male family member would experience difficulties 
obtaining emergency contraception, Bell, Camacho, and Velásquez, (2014) sent male 
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mystery shoppers into pharmacies in three New York City neighborhoods to understand 
their experience. The design of this research was based on previously-established ‘secret 
shopper’ study designs such as those mentioned above. 
Each pharmacy was contacted one time via telephone. If the call was answered, 
this met the criteria for having made ‘contact,’ and the pharmacy would not be 
telephoned again regardless of whether or not any useful information was obtained. If the 
call was left unanswered, the pharmacy would be highlighted in the sampling frame to 
receive a call at another time. Phone calls were made from a quiet, private room in the 
researcher’s home on weekdays between the hours of 8am and 6pm since these are the 
typical pharmacy operating hours. The researcher, presenting herself as a 15-year-old 
girl, followed the semi-structured script with whomever first answered the phone. While 
the caller never requested a transfer to the pharmacist, often the original respondent 
would transfer anyway. If the original call was transferred to a second person (for 
example, if a pharmacy technician transferred the call to a pharmacist), the caller would 
continue the interview with the second person and record the job title of the highest-
ranking person interviewed.  
Sample and Sampling Frame 
Kentucky is divided into five regions: The Jackson Purchase, the Western Coal 
Fields, the Bluegrass Region, the Mississippi Plateau, and the Cumberland Plateau 
(Clotter, 2000). Using a purposive sampling technique to determine which counties to 
request for inclusion in the sampling frame, the counties included were from each of the 
major Kentucky regions as well as urban, rural non-Appalachian, and Appalachian areas. 
The rural sampling frame consisted of 7 counties randomly selected from the Jackson 
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Purchase, Mississippi Plateau, and Western Coal Fields regions (mostly rural regions). 
The Appalachian sampling frame consisted of all listed pharmacies from 7 counties 
randomly selected from the Cumberland Plateau region. The rurality of the selected 
counties was verified using county demographic information available on the County 
Health Rankings and Roadmaps website (University of Wisconsin Population Health 
Institute, 2016). If a county was over 33% rural, it qualified for inclusion. Every 
operating pharmacy in the rural and Appalachian counties included in the sampling frame 
was contacted (n=95). The urban sample consisted of pharmacies randomly selected from 
within the three largest urban areas in Kentucky: Louisville, Lexington, and Bowling 
Green (n=125).  
A list of licensed pharmacies in the selected counties and cities was obtained 
through the Kentucky State Board of Pharmacies. After removing hospital and specialty 
pharmacies, the list included 329 qualifying pharmacies. In total, 67% of all the 
pharmacies listed in the sampling frame were contacted (n=220). However, only those 
pharmacies that regularly stocked EC and had it available at the time of the call 
completed a full interview (n=103). 
Confidentiality 
This study involved an analysis of aggregated data. Confidentiality was 
maintained by not collecting the name of the person being interviewed or any other 
identifying details. Further, while the address and name of the pharmacy were included in 
the sampling frame, this information was not included in the final dataset. Pharmacies 
were labeled as either rural (non-Appalachian), urban, or Appalachian and as either chain 
or non-chain pharmacies. Pharmacies were not labeled by county or specific city. This 
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non-specific labeling method allowed the researcher to answer the given research 
questions while protecting the pharmacies sampled.  
Call Scripts and Data Collection 
The semi-structured interview script was designed to determine the physical 
availability of EC in the pharmacy as well as the pharmacy staff’s understanding about 
proper usage and legal requirements to obtain the drug. The script contained the 
following questions: 
1. Hi. I need to ask about something personal…you’re an adult…like over 18, 
right? (This question was asked to prompt the respondent to confirm that they are 
“over 18” or are presently 18 years of age, or are under 18 years of age, while 
realistically sounding like the phrasing a 15-year-old would plausibly use.) 
2. Do you carry the morning after pill? (If no: Can you recommend a pharmacy 
that would have it?) 
3. Can I get it now?  
4. Do I need a prescription? 
5. Well, I am 15, so do I need to bring my mom or something? 
6. How long after sex before it doesn’t work anymore? (Recorded in hours) 
7. Will it work for sure? 
8. Is it the same like going and getting an abortion? 
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9. Where can I find it in the store? (Asked to determine if it is available on an 
aisle [customer does not have to interact with pharmacy staff], behind the 
pharmacy counter [customer must interact with staff to obtain EC], or other) 
10. How much does it cost? (Recorded cheapest option) 
11. So are you the pharmacist or a tech or…? (Asked to determine the job of the 
person interviewed) 
After the person on the phone confirmed that they were 18 or older, the rest of the 
interview continued as outlined in the flow chart included in Appendix I. The structured 
interviews were pilot tested by calling pharmacies outside of Kentucky and, therefore, 
outside the sampling frame. Data was hand-recorded on standardized forms and coded in 
an Excel document. The Excel data was later imported into SPSS version 24 for analysis.   
Measures 
Characteristics of Pharmacy and Respondents 
 The following four measures describe both the pharmacies and respondents 
generally. These include whether the pharmacy is rural or urban; whether it is a chain or 
private pharmacy; the perceived gender of the respondent; and the respondent’s reported 
job title. Detailed descriptions of these measures are listed below. 
1. Urban/Rural/ Appalachian 
As outlined above, pharmacies were designated as either rural, urban, or 
Appalachian in the dataset. Urban was coded as “1”; rural was coded as “2” and 
Appalachian was coded as “3” in the final SPSS dataset. Because of the similarities 
between the rural and Appalachian samples, this variable was also recoded into 
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Urban/Non-Urban where the pharmacies from Louisville, Lexington and Bowling Green 
were coded as “2” and labeled “Urban” and the pharmacies in the Appalachian and Rural 
samples were combined and coded as “1” for “Non-Urban”.  
2. Chain or private 
Each pharmacy contacted is classified a chain pharmacy (e.g., Walgreens, CVS) 
or as a private pharmacy as reflected in the sampling frame of Kentucky pharmacies 
provided by the Kentucky Board of Pharmacy. In the dataset, chain pharmacies are coded 
as “1” and private pharmacies are coded as “2”. 
3. Perceived Gender  
This measure noted the gender of the person interviewed at the pharmacy as 
subjectively perceived by the caller.  The caller was prepared to list each individual 
answering the call as male, female, or indeterminate. However, all pharmacy employees 
were subjectively perceived to be either very likely male (coded “1”) or very likely 
female (coded “0”). 
4. Reported Job Title 
Near the end of each interview, if the interviewee had not already offered their job 
title or otherwise been clearly identified as the pharmacist, etc., the caller asked some 
version of the question, “So are you the pharmacist?” Upon being asked this or with a 
simple continuation of the question, almost all of the interviewees would readily offer 
their job title. Interviewees were categorized as PHARMACIST, PHARM TECH, 
PHARMACY INTERN, or CASHIER. Only 5 interviewees identified as anything other 
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than a pharmacist or pharmacy technician, so these five were labeled “OTHER” and 
coded as missing in the analysis.  
Physical and Economic Accessibility of EC 
 The five measures included in this category describe the physical availability of 
emergency contraception at the pharmacy as well as the cost. These include whether the 
pharmacy carries EC; whether the respondent recommended another pharmacy if they did 
not carry EC; whether or not they had EC in stock; the product’s location in the store and 
the cost of the product. 
1. Pharmacy Carries EC 
The caller asked in each interview, “Do you carry the morning after pill?” Any 
answer indicating that the pharmacy usually stocked Plan B or any other generic oral 
Emergency Contraceptive was classified as a YES (coded “1”; NO coded “0”) even if the 
pharmacy was out of stock at the time of the call.  
2. If No, Recommends Other Pharmacy 
The caller asked “Do you know where I can get it?” This measure was recorded 
as a YES (coded “1”; NO coded “0”) only if the pharmacy employee directed the caller 
one or more other specific pharmacy by name as a likely source of EC.  
3. Has in Stock Presently 
If told that the pharmacy did carry “the morning after pill,” the caller next asked, 
“Can I get it right now?” to determine that the pharmacy both normally stocked EC and 
had it in stock at the time of the call.  YES was coded 1 and NO was coded 0. 
4. Location within Store 
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In each interview the caller asked were in the store the product was located. 
Answers such as “behind the counter,” or “here in the pharmacy,” were coded as 
BEHIND THE PHARMACY COUNTER (Coded “1”). If the pharmacy employee stated 
that the EC was in a locked case this was recorded as LOCKED ON SALES FLOOR 
(coded “2”). If the product was stated to be “in the store,” “over the counter,” on a given 
aisle or in a given department, but not noted to be in a locked case this was coded as 
SALES FLOOR (coded “3”).  
5. Cost of EC 
The caller asked each respondent for the price of the EC product available at the time 
of the call. The given dollar amount was recorded as stated. If the respondent gave the 
prices of several options, the dollar amount of the cheapest product was recorded. 
Pharmacy Staff Knowledge of EC 
 To determine the likelihood of an adolescent receiving accurate answers to 
questions about emergency contraception, five knowledge-based questions were asked 
during each interview. These questions assessed if a pharmacy staff member knew 
whether or not a prescription was required for purchase; if the caller needed to bring an 
adult to purchase the product; if they knew the timeframe for efficacy of EC; if they knew 
how effective EC is for preventing pregnancy; and whether EC is an abortifacient. If the 
staff member voluntarily stated the percentage of efficacy they believed to be correct, that 
was recorded as well. Also, an overall knowledge scale was developed and included in 
this measurement category. 
1. Requires Prescription 
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The caller asked “Do I need a prescription?” YES (coded “1”; NO coded “0”) is 
recorded for this measure if the pharmacy employee indicated that a prescription was 
required for any purchase of EC or if the employee initially indicated that no prescription 
was required but amended that answer upon hearing that the caller is 15.  
This variable was recoded into a variable that indicated whether the employee’s 
response was correct (consistent with the literature and current laws) or incorrect. 
Incorrect answers included all answers that indicated the caller needed a prescription and 
any uncertain answers. Incorrect answers were coded “0” and correct answers were coded 
“1”. 
2. Requires Adult to Purchase 
The caller would state in each interview that she was 15 and ask “so do I need to 
bring my mom or someone...older?” Any answer indicating that the caller must, should, 
or “would probably need to” bring a parent or at least an adult age 18 was recorded as a 
YES (coded “1”; NO coded “0”). 
This variable was recoded into a variable that indicated whether the employee’s 
response was correct (consistent with the literature and current laws) or incorrect. 
Incorrect answers included all answers that indicated the caller needed to bring an adult 
and any uncertain answers. Incorrect answers were coded “0” and correct answers were 
coded “1”. 
3. Stated efficacy timeframe (in hours) 
The caller asked “How long after sex does it work?” Most pharmacy staff 
answered in a number of hours; most commonly 24, 48, or 72. Any specific number of 
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hours was recorded. If the pharmacy employee answered a range (e.g., “24 to 48 hours”) 
the higher number was recorded. If the answer was unclear or the pharmacy employee 
declined to provide an answer, it was coded as “99” in the dataset and excluded from 
final analysis. 
This variable was recoded into a variable that indicated whether the employee’s 
response was correct (consistent with the literature and current laws) or incorrect. 
Incorrect answers included all answers that underestimated or overestimated the efficacy 
timeframe (more or less than 72 hours after unprotected sex) as well as any uncertain 
answers. Incorrect answers were coded “0” and correct answers were coded “1”. 
4. Perceived Assurance of Efficacy 
 This measure reflected the answers to the caller’s question “Will it work for 
sure?” The answers varied widely and were assigned as affirming a very high likelihood 
of preventing pregnancy YES (coded “1”) if the pharmacy employee offered such 
answers as, “yes,” “definitely,” “absolutely,” “it’s really effective,” “it’s really good,” 
etc., or if the pharmacy employee offered a percent chance of preventing pregnancy of 
95% or higher. Numerical answers lower than 95% or such as “no,” “nothing’s 
guaranteed,” “it’s not 100%”, etc. were coded as NO (coded “0’). 
This variable was recoded into a variable that indicated whether the employee’s 
response was correct (consistent with the literature) or incorrect. Incorrect answers 
included all answers that indicated certainty/near certainty of preventing pregnancy and 
any answers that indicated the employee did not know the efficacy (e.g., “I don’t know” 
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or “I’m not sure”). Incorrect answers were coded “0” and correct answers were coded 
“1”. 
5. Believed % Efficacy if Stated 
Pharmacy staff members were never asked to provide a percent chance of EC 
preventing pregnancy, but many offered a percent chance as part of their answer to the 
question, “Will it work for sure?” Additionally, if the caller were told that the EC would 
“absolutely” or “definitely” work, this was recorded as an answer of 100%, since 
assigning this numerical value would not require subjective evaluation. Any 15-year-old 
caller would reasonably believe such unequivocal terms to mean that EC is literally 100% 
effective.  
6. Stated EC is abortion 
Each interview included the question, “So is it the same like going and getting an 
abortion?” Answers were coded as NO (coded “0”), YES (coded “1”), or UNCLEAR. 
The answers “no,” “it’s not like that,” “I don’t think so,” etc. were coded as NO. Answers 
such as “yes,” “I would say so,” or “anytime you interfere with the pregnancy that’s 
basically an abortion,” were coded as YES. All others were coded as UNCLEAR, 
including declining to answer. Unclear answers were coded as missing and removed from 
analysis. 
This variable was recoded into a variable that indicated whether the employee’s 
response was correct (consistent with the literature) or incorrect. Incorrect answers 
included all answers that indicated emergency contraception is an abortifacient as well as 
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any unclear or unsure answers. Incorrect answers were coded “0” and correct answers 
were coded “1”. 
7. Overall Knowledge Scale 
As previously stated, the answers to the following questions were recoded to 
indicate whether an interviewee’s responses were correct or incorrect: 
1. Do I need a prescription? 
2. Do I need to bring my mom or someone older? 
3. How long after sex does it work? 
4. Will it work for sure? 
5. Is it the same like going and having an abortion? 
Each correct answer was coded as “1” and each incorrect answer was coded as 
“0”. An overall correct answer scale was created by summing these variables. The scale 
ranged from 0-5, with higher scores indicating a greater number of correct responses. 
Attitudes of Pharmacy Staff as Perceived by Caller 
These measures are subjective scorings of the attitudes of the person interviewed. 
The caller ranked each final interviewee on intended helpfulness, apparent discomfort, 
and perceptibly judgmental attitude. Unhelpfulness is ranked on a scale of 1 through 5, 
with 1 being very helpful and 5 being very unhelpful. Incorrect information is not held 
against the interviewee in this measure, as it is strictly a measure of their apparent intent 
to provide assistance to the caller.  Apparent discomfort was measured on a scale of 1 
through 5, with 1 indicating no discomfort and 5 indicating extreme discomfort. 
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Recognized indicators of discomfort included offering equivocal answers, declining to 
answer, taking a long time to answer, etc. Perceived judgmental attitude was measured on 
a scale of 1 through 5, with 1 representing no perceptible judgmental attitude and 5 
representing an extremely judgmental attitude. Indicators of a perceptibly judgmental 
attitude included audible exclamations, assuming an angry tone of voice, or hanging up 
on the caller after hearing her age or when asked questions about abortion.  These three 
measures were summed and averaged to create a 5-point overall negative attitude scale 









To understand the accessibility of emergency contraception in Kentucky 
generally, frequencies and percentages of the variables were obtained using SPSS version 
24. The descriptive results of the sample are detailed below. 
Characteristics of Pharmacy and Respondents 
 Over half (57%) of the pharmacies included in the study were urban while 43% 
were rural. Chain pharmacies made up 49% of the sample, while private pharmacies 
accounted for 51% of the sample. Of those who were interviewed, 76% were perceived to 
be female while just 24% were perceived as male. When asked their job titles, 51% of 
those interviewed identified themselves as pharmacists, 44% said they were pharmacy 
technicians, and 5% reported some other job title. Results are displayed in Table 1. 
Table 1: Descriptive Characteristics of Pharmacies and Respondents 
 Frequency  % 
Urban/Non-Urban (n=220)   
Urban 125 56.8 
Non-Urban 95 43.2 
Chain/Private (n=220)   
Chain 108 49.1 
Private 112 50.9 
Perceived Gender (n=220)   
     Female 167 75.9 
     Male 53 24.1 
Reported Job Title (N=103)   
Pharmacist  53 51.46 
Pharm Tech 45 43.69 
Other 5 4.85 
 
Physical and Economic Accessibility of Emergency Contraception 
 Of the pharmacies called, just over half regularly carried emergency contraception 
(51%). Of those respondents from the 49% of pharmacies that did not carry EC, 61% 
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were able to recommend another pharmacy that carried EC. Of those that carried EC, 
93% had it in stock at the time of the call. The average cost of EC at these pharmacies 
was $42.69 (SD= $8.39). About half (51%) of the pharmacies responded that EC was 
available at that time on their sales floor. Over a quarter (28%) reported that EC was 
located either behind the pharmacy counter or locked on the sales floor. Results are 
reported in Table 4 below. 
 
Table 2: Descriptive Information of Physical and Economic Accessibility to Over-the-Counter Emergency Contraception 
 Frequency  % 
Pharmacy Carries EC (N=220)   
Yes 111 50.5 
No 109 49.5 
Recommends other Pharm if no (N=110)   
Yes 69 62.7 
No 41 37.3 
In Stock Today (N=111)   
Yes 103 92.8 
No 8 7.2 
Location in the Store (N=103)   
Behind Pharmacy Counter 18 17.48 
Locked on Sales Floor 11 10.68 
On Sales Floor 53 51.46 
No Answer/Not Sure 21 20.38 
 Mean SD Min Max 
Reported Cost of EC (N=103)   
Cost $42.69 $8.39 $24.00 $70.00 
   
 
Pharmacy Staff Knowledge of Emergency Contraception 
 Most (95%) of the respondents correctly stated that EC was available without a 
prescription. Although 62% of the respondents correctly stated that the 15-year-old caller 
did not need an adult to purchase EC, 39% responded to this question incorrectly. Over a 
quarter (28%) of respondents did not give the correct answer to the question “how long 
after sex does it work?” Most (55%) of respondents over-estimated how effective EC is 
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for preventing pregnancy. Around one-in-five of those called (22%) either reported that 
using EC is the same as having an abortion or indicated they were unsure. The average 
score on the Overall Knowledge Scale was 3.4 (SD= 1.19) with a minimum score of 0 
(all answers incorrect) and a maximum score of 5 (all answers correct). Results are 
displayed in Table 3 below. 
Table 3: Descriptive Information of Pharmacy Staff Knowledge about Over-the-Counter Emergency Contraception 
 Frequency  % 
Need Prescription (N=103)   
Yes 5 4.9 
No 98 95.1 
Need Adult to Purchase (N=103)   
Yes 38 36.9 
No 63 61.7 
Don’t Know/ Not Sure 2 1.9 
Correct Answer: Efficacy Timeframe (N=103)   
Correct 74 71.84 
Incorrect 29 28.16 
Correct Answer: Efficacy Assurance (N=77)   
Correct 35 45.5 
Incorrect 42 54.5 
EC is the same as Having Abortion (N=102)   
Yes 19 18.6 
No 80 78.4 
Unknown/Unsure 3 2.9 
 Mean SD Min Max 
Overall EC Knowledge (N=103)   
Increases= More correct answers 3.40 1.19 0 5 
 
Perceived Attitudes of Pharmacy Staff 
 The measure of perceived unhelpfulness ranged from 1 to 5 with higher scores 
indicating greater unhelpfulness. The mean score on this measure was 2.38 (SD=1.31) 
with a minimum score of 1 and maximum score of 5. The perceived discomfort measure 
also ranged from 1 to 5 with increases indicating greater discomfort. The mean 
discomfort score was 1.17 (SD=1.19) with a minimum score of 1 and maximum score of 
4. The perceived judgmental attitude measure again included ratings ranging from 1 to 5. 
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The mean value for this measure was 1.67 (SD=1.12) with a minimum score of 1 and a 
maximum score of 4. After the previous three measures were summed and averaged to 
create a 5-point overall negative attitude scale, the mean value was 1.67 (SD= 1.12) with 
a minimum score of 1 and a maximum of 4. Results are displayed in Table 4 below. 
Table 4: Descriptive Information Perceived Attitudes of Pharmacy Staff 
 Mean SD Min Max 
Perceived Unhelpfulness (N=103)   
Increases= Increasingly Unhelpful  2.38 1.31 1 5 
Perceived Discomfort (N=103)     
Increases= Increasingly Uncomfortable  1.17 1.19 1 4 
Perceived Judgmental (N=103)     
Increases= Increasingly Judgmental 1.67 1.12 1 4 
Perceived Negative Attitude (N=103)     
Increases= Increasingly Negative Attitude 1.92 1.04 1 5 
 
Inferential Results 
To explore the data for any relevant differences in affordability, in physical 
accessibility, in pharmacy staff knowledge, and in pharmacy staff attitudes based on 
whether a pharmacy was chain or private and whether a pharmacy was rural or urban, 
chi-square and independent sample T-test analyses have been conducted using SPSS 
version 24. Similar analyses were conducted to test if there were differences in all the 
dependent variables based on whether the respondent was a pharmacist or pharmacy 
technician. After this, four regression models were conducted to test specific hypotheses. 
A sequential logistic regression analysis was conducted to determine if availability of EC 
could be predicted based on whether the pharmacy was rural or urban or if it was chain or 
private. An additional logistic regression analysis was conducted to determine if the 
likelihood of a pharmacy being chain or private could be predicted based on whether it is 
in a rural or urban setting. Then, two sequential linear regression analyses were 
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conducted to determine if chain/private or rural/urban pharmacy statuses were significant 
predictors of pharmacy staff knowledge about emergency contraception and perceived 
negative attitude towards the conversation.  
Associations/Differences between Rural and Urban Pharmacies 
 Chain pharmacies were more likely to be found in urban areas (χ2= 23.06; 
p=.000). Around 63% of urban pharmacies were chain pharmacies while just 30% of the 
rural pharmacies were pharmacy chains. Also significantly associated was the likelihood 
of a pharmacy carrying EC; 61% of urban pharmacies carried EC while just 37% of rural 
pharmacies carried it (χ2= 12.36; p=.000). While only 1.4% of urban pharmacy staff 
members said that a 15-year-old would need a prescription to purchase EC, 13% of rural 
respondents reported that a prescription was necessary (χ2= 6.22; p=.013). Urban 
pharmacy staff members were more likely to correctly know how long after sex EC 
remained effective when compared to rural staff; 82% of urban respondents answered this 
correctly while 63% of rural respondents gave a correct answer (χ2= 4.030; p=.045). 
Similarly, urban pharmacy staff members were more likely to answer correctly when 
asked “is this the same as going and having an abortion?” Of the rural respondents, 64% 
answered this question correctly, while 93% of urban pharmacy staff responded correctly 
(χ2= 11.85; p=.001). The difference in overall EC knowledge between rural and urban 
pharmacies was significantly different (t= 3.07; p=.001). On average, urban staff scored 
3.63 (SD=.956) on the 5-point knowledge scale. Rural staff scored 2.87 (SD=1.50) on 
average. There was also a significant difference in overall negative attitude between these 
two groups (t= 3.53; p=.008). The average score in perceived negative attitude among the 
urban sample was 1.69 (SD=1.18). Among rural pharmacy staff, the average score was 
2.44 (SD=.891). Results are displayed in Table 5. 
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Table 5: Significant Associations/Differences Based on Urban/Rural Pharmacies 
 Urban Rural Total Test Stat 
Chain/Private  f % f % f %  
Chain 79 63.2 29 30.5 108 49.1 χ2=23.06*** 
(.000) Private 46 36.8 66 69.5 112 50.9 
Pharmacy Carries EC  f % f % f %  
Yes 76 60.8 35 36.8 111 50.5 χ2=12.39*** 
(.000) No 49 39.2 60 63.2 109 49.5 
Need Prescription  f % f % f %  
Yes 1 1.4 4 12.9 5 4.9 χ2=6.22* 
(.013) No 71 98.6 27 87.1 98 95.1 
Correct Answer: 
Efficacy Timeframe  
f % f % f %  
Correct 55 82.1 19 63.3 74 76.3 χ2=4.030* 
(.045) Incorrect 12 17.9 11 36.7 23 23.7 
Correct Answer: EC is 
the same as Having 
Abortion  
f % f % f %  
Correct 62 92.5 18 64.3 80 84.2 χ2=11.85*** 
(.001) Incorrect 5 7.5 10 35.7 15 15.8 
Perceived Negative 
Attitude  
M SD M SD M SD  
(Higher Values= 
Worse attitude) 
1.69 1.18 2.44 .891 1.92 1.04 t =3.53** 
(.008) 








Associations/Differences between Chain and Private Pharmacies 
 The likelihood of a pharmacy carrying EC was significantly associated with a 
pharmacy’s designation as either chain or private. While 87% of chain pharmacies 
carried EC, just 15% of private pharmacies carried it (χ2= 113.572; p=.000). Of those 
private pharmacies that carried EC, over a third (35%) were out of stock at the time of the 
phone call, whereas 2% of chain pharmacies reported that the product was not in stock 
(χ2= 23.68; p=.000). Two percent of chain pharmacies told the caller that a prescription 
was required to purchase EC; over a quarter of private pharmacies indicated that a 
prescription was necessary (χ2= 13.40; p=.008). Similarly, chain pharmacies were much 
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more likely than private pharmacies to correctly inform the caller that she did not need to 
bring an adult, with 65% of chain pharmacies and 30% of private pharmacies responded 
correctly (χ2= 4.74; p=.030). Private pharmacies were also more likely to indicate that EC 
is equivalent to having an abortion; 44% of private and 13% of chain pharmacy staff 
indicated that EC caused abortion (χ2= 6.14; p=.013). Overall knowledge of EC between 
chain and private pharmacy staff was significantly different (t=-2.58; p=.011). On 
average, chain staff scored 3.50 (SD=1.11) on the 5-point knowledge scale. Private staff 
scored 2.55 (SD=1.51) on average. While EC knowledge was lower on average in private 
pharmacies when compared to chain pharmacies, EC was reportedly around $7.46 
cheaper at private pharmacies. The average cost of EC at private pharmacies was $36.05; 
the average cost at chain pharmacies was $43.51(t= 2.88; p=.005). There was a 
significant difference in overall negative attitude between these two groups (t= -2.13; 
p=.006). The average score in perceived negative attitude among the chain sample was 
1.83 (SD=.960). Among private pharmacy staff, the average score was 2.73 (SD=1.37). 












Table 6: Significant Differences and Associations Based on Chain/Private Pharmacies 
 Chain Private Total Test Stat 
Pharmacy Carries EC  f % f % f %  
Yes 94 87.0 17 15.2 109 49.1 χ2=113.572*** 
(.000) No 14 13.0 95 84.7 111 50.9 
EC in Stock f % f % f %  
Yes 92 97.9 11 64.7 103 92.8 χ2=23.68*** 
(.000) No 2 2.1 6 35.3 8 7.2 
Need Prescription  f % f % f %  
Yes 2 2.2 3 27.3 5 4.9 χ2=13.40** 
(.008) No 90 97.8 8 72.7 98 95.1 
Correct Answer: Needs 
Adult  
f % f % f %  
Correct 60 65.2 3 30.0 63 62.4 χ2=4.74* 
(.030) Incorrect 32 34.8 7 70.0 38 37.6 
Correct Answer: EC is the 
same as Having Abortion  
f % f % f %  
Correct 75 87.2 5 55.6 80 84.2 χ2=6.14* 
(.013) Incorrect 11 12.8 4 44.4 15 15.8 
Price M SD M SD M SD  








M SD M SD M SD  
(Higher Values= Worse 
attitude) 
1.82 0.96 2.73 1.37 1.92 1.04 t =-2.13** 
(.006) 
Correct Answers Total  M SD M SD M SD  
(Higher values=More 
Discomfort) 
3.50 1.11 2.55 1.51 3.40 1.19 t =-2.58** 
(.011) 
 
Associations/ Differences between Pharmacists and Pharmacy Technicians  
 The only significant difference between pharmacists and pharmacy technicians 
was perceived gender. Of the pharmacists interviewed 47.1% were perceived to be male 
and 52.8% were perceived as female. Of the pharmacy technicians, only 20% were 
perceived as male while 80% were perceived to be female (χ2= 7.93; p=.005). There were 
no other significant differences between pharmacists or pharmacy technicians, including 




Table 7: Associations/Differences Based on Job Title 
 Pharmacist Pharm Tech Total Test Stat 
Perceived Gender  f % f % f %  
Female 28 52.8 36 80 64 65.3 χ
2=7.929** 
(.005) Male 25 47.1 9 20 34 34.7 
Perceived Negative Attitude  M SD M SD M SD  
(Higher Values= Worse 
attitude) 
1.91 1.02 1.85 .944 1.92 1.04 t =.269 
(.787) 
Correct Answers Total  M SD M SD M SD  
(Higher values=Correct 
Knowledge Answers) 
3.32 1.16 3.56 1.18 3.40 1.19 t =-.993 
(.323) 
Factors on Likelihood of Pharmacy Carrying Emergency Contraception 
The null hypotheses for this analysis were: 
H∅1= There will be no relationship between the likelihood of a pharmacy 
carrying EC and whether a pharmacy was a chain or private while 
accounting for other relevant factors. 
H∅2= There will be no relationship between the likelihood of a pharmacy 
carrying EC and whether a pharmacy was urban or rural while accounting 
for other relevant factors. 
The dependent variable in this model was whether a pharmacy regularly carried EC. The 
independent variables of interest were “rural vs. urban” and “chain vs. private” pharmacy 
status. Perceived gender was a control variable in this analysis. 
  In the control model, perceived gender was a significant predictor of whether a 
pharmacy carries emergency contraception. Pharmacies where a male staff member 
responded were over three times as likely to carry EC (OR=3.26; p=.001). This first 
model was significant (χ2= 12.605, df=1; N=220; p=.000). Based on the pseudo-R 
estimates, the control model accounted for between 6% (Cox & Snell R2= .057) and 8% 
(Nagelkerke R2= .076) of the variance.  
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The addition of the chain vs. private pharmacy variable in the second model, 
perceived gender was no longer a significant factor. Holding gender constant, whether the 
pharmacy was chain or private was a significant predictor of whether the pharmacy 
carried EC. The odds of a pharmacy carrying EC are 97% lower when the pharmacy was 
privately operated (OR= .028; p=.000). This model was also itself significant (χ2= 
129.926, df=2; N=220; p=.000). Based on the pseudo-R estimates, the second model 
accounted for between 45% (Cox & Snell R2= .446) and 60% (Nagelkerke R2= .595) of 
the variance. This addition improved the model fit by 39-52%.  
In the full model, the urban vs. rural variable was added, but it was not a 
significant predictor. The chain vs. private pharmacy variable remains significant at about 
the same level (OR= .027; p=.000). The full model was significant (χ2= 130.005, df=3; 
N=220; p=.000). The addition of the urban vs. rural variable did not change the pseudo-R 
estimates; and, therefore, did not significantly improve the model fit. Hence, we rejected 
H∅1 but failed to reject H∅2. Results are reported in Table 8. 
Table 8: Logistic Regression Results- Factors on Likelihood of Carrying EC 






























-- -- .887 
(.426) 




Urban or Non-Urban Location on Likelihood of Pharmacy Being Chain or 
Private 
The null hypothesis associated with this analysis was as follows: 
H∅= There will be no relationship between the likelihood of a pharmacy 
being chain or private and whether a pharmacy was in a rural or urban 
setting. 
The dependent variable in this model was whether a pharmacy is a chain or privately 
operated and the only independent variable was whether a pharmacy was urban or non-
urban/rural. In this model, the location of the pharmacy (rural vs. urban) was a significant 
predictor of whether a pharmacy was privately operated or a chain.  An urban pharmacy 
was 74% less likely to be privately operated than a non-urban pharmacy (OR= .256; 
p=.000). Model was significant (χ2= 23.542, df =1; N=220; p=.000). Based on the 
pseudo-R estimates, the second model accounted for between 10% (Cox & Snell R2= 
.101) and 14% (Nagelkerke R2= .135) of the variance. Given these results, H∅ was 
rejected.  
Factors on Pharmacy Staff Knowledge of Emergency Contraception 
 The null hypotheses associated with this analysis were as follows: 
H∅1= There will be no relationship between the pharmacy staff knowledge 
of EC and whether a pharmacy was a chain or private while accounting for 
other relevant factors. 
H∅2= There will be no relationship between the pharmacy staff knowledge 
of EC and whether a pharmacy was urban or rural while accounting for 
other relevant factors. 
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The dependent variable in this model was the 5-point overall EC knowledge scale 
described in the measurements above. The independent variables of interest were “rural 
vs. urban” and “chain vs. private” pharmacy status. The control variables were perceived 
gender and job title. 
Neither control variable (perceived gender and job title) was a significant 
predictor of pharmacy staff knowledge of EC in the control model. The second model 
adds the “private vs. chain” pharmacy variable. With the inclusion of this variable, the 
gender and job title were still not significant predictors. Whether a pharmacy was a chain 
or private pharmacy was a significant predictor while controlling for gender and job title. 
Pharmacy staff from private pharmacies were expected to score over half a point lower 
on the overall knowledge scale (β= .637; p=.010). The third model added the “urban vs. 
rural” variable. When this variable was included, whether a pharmacy was chain or 
private was no longer a statistically significant predictor. However, whether a pharmacy 
was located in a rural or urban area was a significant predictor of pharmacy staff 
knowledge while controlling for gender, job title, and chain/private pharmacy status. 
Pharmacy staff members from urban pharmacies were expected to score over half a point 
higher on the overall knowledge scale when compared to staff members from rural 
pharmacies (β=.608; p=.016).  
 The full model explains nearly 14% of the total variance (R2 = .136). This 
indicated an improvement in model fit of nearly 13% when compared to the control 
model (R2 = .012). When compared to the second model, the full model improved model 
fit by around 6% (R2 = .080). The entire model was also significant (F=3.655; p=.008). 
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Given these results H∅2 was rejected while we failed to reject H∅1. The results are 
displayed in Table 9. 
Table 9: Linear Regression Results- Factors on Overall Knowledge of EC 












































-- -- .608* 
(.248) 
Standard errors are reported in parentheses; *p < .05; **p < .01; ***p <.001 
 
Factors on Perceived Negative Attitude of Pharmacy Staff  
The null hypotheses associated with this analysis were as follows: 
H∅1= There will be no relationship between the negative attitude of the 
pharmacy staff and whether a pharmacy was a chain or private while 
accounting for other relevant factors. 
H∅2= There will be no relationship between the negative attitude of the 
pharmacy staff and whether a pharmacy was urban or rural while 
accounting for other relevant factors. 
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The dependent variable in this model was the 5-point Perceived Negative Attitude scale 
described in the measurements above. Again, the independent variables of interest were 
“rural vs. urban” and “chain vs. private” pharmacy status. The control variables were 
perceived gender and job title. 
Neither control variable (perceived gender and job title) was a significant 
predictor of pharmacy staff attitudes in this first model. The second model added the 
“private vs. chain” pharmacy variable. Neither the new variable nor the original control 
variables were significant in this second model. The third model added the “urban vs. 
rural” variable, which was a significant predictor of perceived attitudes of the pharmacy 
staff. Pharmacy staff from urban areas were expected to have a score over a half point 
lower on the negative attitude scale than those from rural areas (β= -.622; p= .007). 
Interestingly, the inclusion of this variable also rendered the perceived gender variable 
significant. Perceived male members of pharmacy staff were expected to have a negative 
attitude score of nearly a half point higher than those perceived female (β= -.464; p= 
.028).  
 The full model explained nearly 13% of the total variance (R2 = .129). This 
indicated an improvement in model fit of nearly 9% when compared to the control model 
(R2 = .035). When compared to the second model, the full model improved model fit by 
around 7% (R2 = .057). The entire model was also significant (F=3.438; p=.011). Given 





Table 10: Linear Regression Results- Factors on Perceived Negative Attitude of Pharmacy Staff 










































-- -- -.622** 
(.244) 
Standard errors are reported in parentheses; *p < .05; **p < .01; ***p <.001 
 
Additional Comments 
Occasionally during the interviews, a respondent would provide anecdotal 
information which would be recorded. The following is a list of these details: 
1. 5 respondents offered to order EC when it was not in stock 
2. 4 mentioned the local health department or a free clinic as a source of free EC 
3. 3 suggested talking to a doctor instead of calling the pharmacy 
4. 2 indicated low-demand as the reason they do not carry EC (“It expired on the 
shelf’) 
5. 1 refused to check the price 
6. 1 recommended an out-of-county pharmacy 
7. 1 told the caller that insurance may cover it 
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8. 1 recommended that the caller seek long-term birth control because EC is “a 
backup method” 
After asking the question about whether EC is the same as having an abortion, 
many respondents would explain how EC works or offer other comments. The following 
list details these remarks. 
1. 6 respondents correctly indicated that it will not harm an existing pregnancy 
2. 7 incorrectly indicated that it could potentially harm an existing pregnancy 
and/or cause abortion 
3. 3 respondents correctly indicated that it blocks fertilization 
4. 2 correctly indicated that it prevents ovulation  
5. 1 indicated that it triggers menstruation 
6. 1 said “it prevents the baby from forming” 
7. 1 said “it’s not abortion but I don’t know how it works”  
8. 2 verbally refused to answer this question 











 DISCUSSION AND RECOMMENDATIONS 
 
As demonstrated in this study, adolescents seeking information about over-the-
counter emergency contraception in Kentucky were likely to face many barriers. 
Although barriers to EC were found throughout the state, they were especially 
concentrated in rural areas. Prior research in other states has demonstrated rural 
disparities in access to EC products and accurate information relating to emergency 
contraception (Mackin & Clark, 2011; Samson et. al., 2013; Gaffaney et. al, 2015). This 
study demonstrated that similar inequities between rural and urban areas exist in the state 
of Kentucky.  
Physical and Economic Barriers to Emergency Contraception  
Nearly half of the pharmacies called did not carry EC at all. Further, over a third 
of pharmacies that did not carry EC were not able to recommend an alternative provider. 
Those pharmacies were more likely to be private, rural pharmacies. These results are 
consistent with the 2013 Kansas “secret shopper” study (Samson et al., 2013) which 
found that urban pharmacies were twice as likely to have EC available at the time of the 
call as were those in rural areas. This study also found that chain or private pharmacy 
status was a better predictor of EC availability than was rural or urban status alone. 
Seven-in-ten private pharmacies surveyed did not stock over-the-counter EC, and the 
choice of merchandise stocked at chain pharmacies is dictated by corporate policies 
developed outside the state. Therefore, except for those pharmacies obligated by 
company-wide policy to carry the product, most of the surveyed Kentucky pharmacies 
opted not to carry it. The specific reasons for this practice are unidentified and beyond the 
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scope of this research. Still, recognizing that there were differences between urban and 
rural availability is imperative. The fact that an urban pharmacy was 74% less likely to be 
privately-operated means that the lack of availability in private pharmacies affected those 
in rural areas most.  
About half of the surveyed pharmacies stored their EC in a manner that requires 
an adolescent seeking EC to interact with an employee (either locked on the sales floor or 
behind the pharmacy counter). Anxiety about having to discuss personal and potentially 
embarrassing information with an unknown staff member has been determined to be a 
deterrent for an adolescent (Gaffaney, et al., 2015). Per the data, chain pharmacies were 
more likely to have EC available unlocked on the sales floor, and chain pharmacies are 
concentrated mostly in urban areas. Again, rural Kentucky adolescents would face greater 
barriers to obtaining the product. 
The findings in this study demonstrated that EC price may also be a barrier for 
teenagers in Kentucky. If paid out-of-pocket, the average cost of EC in the state is 
$42.69, which is likely not affordable for most teenagers. However, EC in private 
pharmacies was found to be $7.46 cheaper than EC in chain pharmacies. While $36.05, 
the average cost of EC at private pharmacies stocking EC, may be more affordable, it is 
important to note that most private pharmacies did not carry EC at all while chain 
pharmacies were nearly twice as likely to stock it. As mentioned in prior research (e.g., 
Bell, Camacho, & Velasquez, 2014), the price of over-the-counter EC can be an 
economic barrier to obtaining EC in a sufficiently timely manner. 
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Pharmacy Staff-Associated Barriers to Emergency Contraception 
Staff-associated barriers are those barriers that exist only as a result of 
misinformation provided to the adolescent customer. These barriers may include lack of 
knowledge on the part of pharmacy staff and/or attitudes of pharmacy staff which may 
motivate them to prevent access to EC. 
Barriers Created by Lack of Knowledge among Pharmacy Staff 
 In this study, the average negative attitude score was low, only 1.92 out of 5. 
However, the overall knowledge average was 3.4 out of 5 indicating several gaps in 
knowledge. Consistent with the literature, this finding indicated that an honest lack of 
knowledge may be a greater barrier than attitudes against providing EC to adolescents. 
Studies discussed in the literature review found pharmacy staff lack of knowledge to be a 
significant barrier to timely access to EC among their clients. Wilkinson and colleagues 
(2012) found that researchers acting as physicians needing information about age 
restrictions to over-the-counter EC access were nearly as likely to have received the 
wrong information as researchers pretending to be adolescents. This indicates that the 
pharmacy staff members were truly uninformed rather than intentionally deceptive.  
 Of the Kentucky pharmacies interviewed for this study, 95% correctly stated that 
no prescription was required, and only 38% incorrectly stated an age requirement. 
However, 65% of those answering correctly were chain pharmacies, which are 
concentrated in urban areas. Therefore, misinformation about age requirements more 
heavily affects rural areas of the state. Previous research by Wilkerson and colleagues 
(2012) and Orr and colleagues (2015) found that more than half of the pharmacies 
included in their studies provided the incorrect age requirement for EC purchase without 
a prescription.  
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 Over a quarter (28%) of sampled pharmacies in this study reported an incorrect 
efficacy timeframe for EC (up to 72 hours) with 37% of rural pharmacies giving an 
incorrect timeframe, compared to just 18% of urban pharmacies. Further, 55% incorrectly 
stated how effective EC is, typically overestimating its efficacy, and only one pharmacy 
recommended that the caller seek a long-term birth control method. These findings are 
problematic as demonstrated in the literature. Baird and colleagues (2015) discussed how 
improper use and overestimation of EC’s effectiveness leads to overreliance on EC as a 
primary birth control method. Similarly, in their 2012 study of Utah women who used EC 
more than once during the year, Melton, Stanford and Dewitt found that successfully 
using EC once led repeat users to overestimate its effectiveness. If Kentucky pharmacy 
staff workers are misleading their customers into misusing EC, they are contributing to 
the problem of overreliance on a birth control method that can readily fail to prevent 
pregnancy if not used in a timely and correct manner.  
 In 2011, Mackin and Clark found that 38% of surveyed Iowa pharmacists 
believed that over-the-counter EC functioned as an abortifacient. Similarly, Richman and 
colleagues (2012) found that 46% of Florida pharmacists who responded to their survey 
believed that EC induced abortion. Compared to these previous findings, the rate at 
which Kentucky pharmacy staff members told the interviewer that EC caused an abortion 
was much lower: just over 1-in-5 (21.6%) gave this answer. While that is comparatively 
better, the number still indicates that misinformation perpetuating the idea that over-the-
counter EC functions as an abortifacient remains a concern. Whether this was simple a 
misunderstanding or a moral objection on the part of the pharmacy staff member, the 
issue needs to be addressed. Telling an adolescent client that EC can cause an abortion 
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may inadvertently make the pill seem much more effective in preventing pregnancy than 
it actually is, further contributing to the problem of overreliance.  
Pharmacy Staff Attitudinal Barriers  
 The negative attitude scale was a 5-point scale based on subjective scorings of the 
attitudes of the person interviewed. The perceived attitudes included in this measure were 
unhelpfulness, discomfort, and judgmental nature. Overall, negative attitude scores were 
low with an average of 1.92 out of 5. However, teenagers in rural areas are more likely to 
encounter negative attitudes when seeking EC. The linear regression results indicated that 
urban pharmacy staff members were expected to score more than half a point lower on 
the 5-point scale than those in rural areas. On average, urban pharmacies scored 1.69 out 
of 5 on perceived negative attitude; rural pharmacies scored 2.44 out of 5 on average. 
This was in line with the findings of Richard, Kinzey, and Masters (2015) in their study 
of rural pharmacist attitudes toward contraception in general. Most of the rural 
pharmacists surveyed in that study demonstrated discomfort about providing over-the-
counter access to contraception to their patients and many actively opposed the 
prescription of contraceptives (Richard, Kinzey, and Masters, 2015). It is important to 
note that, while the negative attitude average among the rural sample was significantly 
higher than those in the urban sample, it was still lower than half. Although perceived 
negative attitude is a recognized barrier for rural EC access, lack of knowledge among 
the pharmacy staff likely plays a greater role and offers a more effective route for 
intervention.  
Pharmacy Technicians vs. Pharmacists  
 For the most part, counseling on EC was lacking in this study. For example, 
higher body weight reduces the efficacy of over-the-counter EC and women should be 
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advised to transition to a permanent form of birth control with higher efficacy (Cleland, 
Raymond, Westley & Trussell, 2014). However, only one pharmacist in this study 
recommended a long-term birth control and none mentioned the weight contraindication. 
This is consistent with Young, Griffin, and Vest (2013) who that found that, despite their 
pharmaceutical education, pharmacists are underprepared to counsel those seeking over-
the-counter emergency contraception. 
 Young, Griffin and Vest (2013) found that just 25% of the 200 graduating 
students from Midwestern University’s College of Pharmacy in the study felt confident in 
counseling patients on EC use. The most common self-reported barrier in that study was 
lack of knowledge. Of those interviewed in this study, 51.46% were pharmacists and 
43.69% were pharmacy technicians with the remaining 4.85% being some “other” 
professional. Because of their educational level, it is reasonable to expect a pharmacist to 
answer the knowledge-based questions more accurately than a pharmacy technician. 
However, this study found no difference in overall knowledge or negative attitudes 
between pharmacists and pharmacy technicians.   
Study Strengths  
 This research was the first effort to understand pharmacy-based barriers to 
adolescent access to over-the-counter contraception through a simulated experience in the 
state of Kentucky. Unlike survey research that would rely on adolescent’s self-reporting 
their own experiences, this study allowed the researcher to witness the pharmacy-
adolescent interaction, reducing the risk of report bias. Additionally, only one researcher 
made the phone calls included in this study. Therefore, there was a level of 
standardization in that every respondent talked to the same person. This helped assure 
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that believability of the phone call and the framing of the questions was generally 
consistent. 
Unlike other “secret shopper” studies conducted to determine a teen’s experience 
while seeking over-the-counter EC in a pharmacy setting, this research utilized regression 
analyses to control for other factors that could impact knowledge, attitudes, and EC 
availability beyond “rural vs. urban” and “chain vs. private.” Additionally, this research 
looked at the impact of pharmacy operation type. The inclusion of the “chain vs. private” 
measure in addition to the “rural vs. urban” measure provided a better understanding of 
what factors determine EC availability in a pharmacy. While past “secret shopper” 
studies of this topic identified a disparity between urban and rural availability of over-
the-counter EC (Gaffaney et al., 2015; Wilkinson et al., 2012), they did not control for 
the influence of “chain vs. private” which may have confounded their results. Only one 
previous survey on EC availability, conducted by Samson and colleagues (2013) 
controlled for “chain vs. private,” but that survey, conducted in 2012 (before the 2013 
regulatory change) was not a “secret shopper” study and did not control for any 
characteristics of the respondent.  
Study Limitations 
 The non-probability sampling technique of this study was one of its major 
limitations. The number of counties chosen for the rural/Appalachian sample was 
determined based on the affordability of obtaining the per-county list of registered 
pharmacies from the Kentucky Board of Pharmacies. Due to limited time and resources, 
the sample may not be representative of the entire state. 
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 Since the interviews were semi-structured, questioning and responses were often 
altered based on the unanticipated flow of conversation. Generally, the caller tried to 
follow the script as written, but occasionally the interviewees’ responses or tone of voice 
caused the researcher to ask questions differently due to such occurrences as emotional 
arousal or simply because the interviewee offered answers to questions that were not yet 
asked. Therefore, these interviews were not standardized although the same information 
was sought during each one.  
 The questions assessing perceived negative attitudes were based on one 
researcher’s perception of a respondent’s unhelpfulness, discomfort, and judgmental 
nature. Hence, these measures were completely subjective and another researcher may 
have perceived these conversations differently. Originally, the study design included 
recording the audio of these interviews and having other researchers rate the 
conversations based on these measures. However, the Institutional Review Board did not 
approve of recording the interviews. 
 This research should be considered as justification for further investigation into 
the distribution of pharmacy-based barriers to adolescent access to over-the-counter EC 
in our state. This study added to the body of literature it this area and future research into 
should work to overcome the study limitations outlined above.  
Recommendations 
 The primary pharmacy staff-associated barrier identified in this research was lack 
of knowledge. The research also revealed that, while barriers were evident throughout the 
state, all measured barriers were more heavily concentrated in rural areas of Kentucky. 
The following recommendations are based primarily on these findings. 
75 
 
 First, because of the time restricted nature of this product and the fact that it is 
only to be used as a last resort, pharmacy staff should receive more training on how to 
accurately and knowledgably counsel anyone seeking over-the-counter EC and how to 
best discuss this topic with adolescent clients. Several studies have found that adequate 
counseling in the pharmacy setting leads to proper EC use and better outcomes for both 
pharmacy staff and clients. Ragland, Payakachat, and Stafford (2015) found that when 
pharmacy students counseled female participants for just ten minutes on the basics of use 
of and access to EC, the women immediately scored higher on tests measuring their 
knowledge of EC. The follow-up tests conducted several months later also showed 
significantly higher scores in EC knowledge, demonstrating that a minimal 10-minute 
educational exercise a pharmacy setting can lead to an immediate increase in 
understanding of EC and continued retention of this knowledge. Batra, Aquilino, and 
Farris (2015) evaluated pharmacy staff of 55 pharmacies that had all participated in 
online education intervention aimed at demonstrating what they can do as healthcare 
professionals to decrease unplanned pregnancy. After intervention, the authors found that 
90% of participating staff reported more confidence in discussing contraceptives because 
of the intervention and wanted to prioritize the topic. Young, Griffin, and Vest (2013) 
studied two hundred third-year pharmacy students who participated in hands-on skits to 
practice emergency contraceptive counseling. Prior to the workshop, only 25% of the 
pharmacy students reported confidence in counseling patients on EC use. Following 
participation in the exercise, 58.8% reported confidence in their counseling EC ability. 
Given that prior evidence supports the efficacy of pharmacy-based counseling and that 
the pharmacy staff are the experts available at the point of purchase, interventions to 
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improve their ability to adequately counsel anyone seeking over-the-counter EC as well 
as teenagers specifically should be developed and implemented throughout the state and 
especially in rural regions. 
 Second, the public generally should be better informed about the proper use of 
over-the-counter EC, the current lack of age restriction, and general facts about how it 
functions and its efficacy. Devine (2012), seeking to explain why increased access to 
over-the-counter EC did not result in a decrease in unintended pregnancies, argued that 
lack of effectiveness to a combination of lack of awareness of the nature of EC and its 
over-the-counter status, the incorrect belief that it is an abortifacient, privacy concerns, 
and concerns over adverse health effects among the general public. Baird and colleagues 
(2015) argued that in addition to the need for greater public awareness of and access to 
emergency contraception, public health interventions need to aim at ensuring that women 
who use EC will transition successfully afterwards to regular, more effective birth control 
methods and to prevent overreliance on EC. Melton, Stanford, and Dewitt (2012) studied 
women who had used EC more than twice in the year to better understand overreliance. 
They found that most repeat users overestimated the efficacy of the products. The authors 
asserted that women who repeatedly use EC successfully likely overestimate its 
effectiveness. Efforts to increase access must also avoid inducing dependence on EC as 
more than a backup method of contraception. Therefore, along with removing 
accessibility barriers to over-the-counter EC, it is the responsibility of the public health 
system to assure that as many women as possible receive accurate information about 
proper use of EC. This goal may be best achieved via a social marketing or mass media 
campaign implemented throughout the state of Kentucky and in rural areas specifically.  
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 In addition to creating a mass public health education campaign to increase 
general knowledge of the proper use of EC, the public health system should better 
advertise the fact that, in the state of Kentucky, emergency birth control is offered 
through health department clinics free of charge in addition to other family planning 
services (Kentucky Cabinet for Health and Family Services, 2015). While hours and 
locations of the health departments may pose barriers for adolescents who lack 
transportation or who are attending school, for those who can get to the health 
department, it removes the financial burden and includes accurate EC counseling and 
referrals to other services such as those providing long-term birth control and STI testing 
(Kentucky Cabinet for Health and Family Services, 2015).  
 Third, adolescents should have access to accurate knowledge about their 
reproductive health and about contraception generally. A significant problem facing teens 
is a lack of reproductive education. The number of American female adolescents 
receiving no formal instruction in school about birth control methods rose to 26% as of 
2013 (Guttmacher Institute, 2016d). This lack of education is most concentrated in rural 
America:  as of 2013 only 48% of adolescent females in rural counties were receiving 
formal education on birth control methods and in 2014, only 35% of high schools 
reported that they included proper condom use in their reproductive health curriculum 
(Guttmacher Institute, 2016d). A 2011 study by Kathrin Stanger-Hall and David W. Hall 
found a high correlation between those states with school curricula requiring or 
promoting abstinence as the only safer-sex option and those states with higher teen 
pregnancy and birth rates. Even when controlled for socio-economic status and race, the 
study found that states which adopted more comprehensive sex-education programs had 
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lower rates of unintended teen pregnancy while those providing abstinence-only 
education had the highest rates of unintended teen pregnancy (Stanger-Hall & Hall, 
2011). While this type of intervention would likely face social opposition in the areas of 
our state that are most affected by teenage pregnancy, formal education on reproductive 
health, safe sex, and contraception, including education on the proper use of over-the-
counter EC, is one of the most effective ways for preventing unintended pregnancy and 


























 It is critical that every individual receive accurate information that allows them to 
make informed decisions about their own body and health, including reproductive health. 
This includes adolescents, who are among the most at-risk and least advantaged members 
of our society. Adolescents typically lack the education, the financial resources, and the 
personal freedom needed for self-determination. Yet the reproductive decisions they 
make or have made for them may follow them and determine the course of the rest of 
their lives. The limited contraceptive options available to adolescents may become even 
more restricted. Given the present precarious nature of reproductive healthcare funding 
and availability, Emergency Contraception has never been a more important tool for 
those members of our society who have the least access to contraceptive options. 
Therefore, those who are regarded as experts within the pharmacy should be informed 
and empowered to meet their responsibility of providing effective counseling to clients 
seeking over-the-counter EC. 
 The recommendations offered in this thesis are consistent with the reproductive 
health goals set forth by Healthy People 2020 plan and Public Health 3.0. One of the 
Healthy People objectives for family planning is to lower unintended pregnancy by 10% 
by 2020. This objective falls within the overall goal of improving pregnancy planning 
and spacing and preventing unintended pregnancy generally (HHS, 2014). Public Health 
3.0, building on the work of Healthy People 2020, calls on public health practitioners to 
work across sectors and advocate for public health policies and programs that promote 
health equity by directly affecting the social determinants of health. Education is one of 
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the key social determinants identified by Public Health 3.0 as needing greater attention by 
the public health system (HHS, 2016).  Since unintended pregnancy is correlated with 
lower educational attainment (Guttmacher Institute, 2016a), advocating for better 
reproductive and contraceptive education for both adolescents and the public at large can 
contribute to improving overall educational attainment, especially among at-risk 
populations. Efforts to rescind the reproductive options guaranteed under the Patient 
Protection and Affordable Care Act, to defund many reproductive healthcare providers, 
and to allow employers religious exemptions from contraceptive coverage will, if 
realized, frustrate plans to increase contraceptive access, to reduce unintended 
pregnancies, and to achieve health equity on this front.  
 The results and recommendations presented herein represent a timely contribution 
to the effort to understand how better to make EC available to the public, to inform those 
seeking EC of its proper usage, and to continue to advance the public health interests of 
the American people in the face of even greater adversity than previously expected.  
 This thesis successfully answered each of the five research questions set forth in 
the Purpose of the Study. In summary, analysis of the collected data revealed that: 
1. Yes, there were differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes based on 
whether a pharmacy is rural or urban. These differences were demonstrated 
via the preliminary analyses and offer insight into the specific disparities 
between the urban and rural Kentucky pharmacies in the survey.  
2. Yes, there were differences in/associations between affordability, physical 
accessibility, pharmacy staff knowledge and pharmacy staff attitudes based on 
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whether a pharmacy is chain or privately owned. Again, these differences 
were discovered initially through the preliminary analyses. While the 
differences based on chain or privately-owned status were themselves 
informative, the fact that urban pharmacies were 74% less likely to be 
privately-owned and that chain pharmacies performed better on nearly every 
measure further revealed the inequities faced by those in rural parts of the 
state. 
3. Yes, factors such as whether a pharmacy was chain or privately operated or 
whether it was urban or rural did in fact predict a pharmacy’s likelihood of 
carrying EC. While initially it seemed that “urban or rural” was a significant 
factor in whether the pharmacy carried over-the-counter EC, the final model 
demonstrated that whether a pharmacy was a chain or privately owned was a 
better predictor of whether the pharmacy carries the product. 
4. Yes, factors such as whether a pharmacy was chain or privately operated or 
whether it was urban or rural did predict the level of EC knowledge among 
pharmacy staff. Here it seemed initially that the chain or private status of a 
pharmacy played a role in the overall knowledge level of its staff. However, 
the final model showed that, in fact, rural or urban location was a better 
predictor of overall EC knowledge. 
5. Yes, factors such as whether a pharmacy was chain or privately operated or 
whether it was urban or rural did predict the level of negative attitudes 
demonstrated by pharmacy staff. As with question four, in the first model the 
chain or private status of a pharmacy appeared to play a role in the staff’s 
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level of negative attitudes. However, the final model showed that, in fact, rural 
or urban location was a better predictor of overall negative attitudes as well. 
Still, it is important to recall that this measure was subjective as mentioned in 
the study limitations section of this thesis. 
By answering the selected research questions, this thesis made three distinct contributions 
to the field of knowledge in public health.  
 First, this thesis represents the first time that data on the availability of over-the-
counter EC to adolescents in the state of Kentucky has been collected and presented. 
Indeed, the relevant literature reveals that extensive collection and analysis of data 
derived from interactions which simulated the experience of an adolescent seeking EC 
have been conducted in only a few other states. The addition of this unique data and its 
analysis to the literature is not only useful for further study of over-the-counter 
Emergency Contraception accessibility in Kentucky pharmacies and for use in the design 
of public health interventions within the state; it also serves to increase the understanding 
of over-the-counter Emergency Contraception access nationwide when added to the 
extant literature on EC access in other states. 
 Second, this thesis added to the literature consideration of a factor not accounted 
for in other “secret shopper” studies of barriers to emergency contraception access; 
namely, the chain or private ownership of the pharmacies surveyed. This thesis has 
identified chain vs. private ownership as the foremost determining factor in whether a 
pharmacy carries over-the-counter EC. It is likely that the corporate policies of the chain 
pharmacies obligated them to offer over-the-counter EC. Therefore, this study found that 
when a pharmacy was not obligated by policy to carry the product, most of the surveyed 
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Kentucky pharmacies elected to not carry it. However, many factors beyond the scope of 
this thesis may contribute to this, such as differences in pharmacist and staff education or 
employer provided training, differences in religious and other beliefs, the effect of an 
urban or rural environment on those beliefs, financial burdens faced by the private 
pharmacies, and so on. In any case, the role of chain vs. private ownership should be 
included in any further research into pharmacy-based barriers to EC access, and should 
also be considered in the planning of future public health policy and interventions 
regarding over-the-counter Emergency Contraception access. 
 Third, this thesis demonstrated that barriers to over-the-counter Emergency 
Contraception access, while prevalent across Kentucky, were much higher in the state’s 
rural counties. As previously stated, the greatest factor in predicting that a pharmacy 
would not carry EC was shown to be private ownership. Seven-in-ten of Kentucky’s rural 
pharmacies are privately operated, and private pharmacies were only about half as likely 
to carry EC as are chain pharmacies, regardless of urban or rural setting. Given that chain 
pharmacies were concentrated in urban counties, the state’s rural population has limited 
access to chain pharmacies and relies primarily on private pharmacies. Thus, many small 
population centers may have no local pharmacy access to EC at all.  
In addition to the greater likelihood of rural pharmacies being private and, 
therefore, less likely to carry Emergency Contraception, this thesis also revealed that, on 
average, rural pharmacy staff in the sample were less helpful when asked for information 
about EC, more judgmental of a perceived adolescent asking for EC, more uncomfortable 
discussing EC with an adolescent, less knowledgeable of the proper use, efficacy, and 
legal status of over-the-counter EC than their  urban peers, and less likely to be able to 
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refer the caller to another pharmacy. The data also revealed the average cost of EC at 
private pharmacies that did carry EC to be lower than at chain stores; however, this 
advantage would be of no benefit to most rural residents of Kentucky due to the low 
number of private, rural pharmacies stocking EC.    
 In summary, this thesis has identified the key factors determining adolescent 
barriers to over-the-counter Emergency Contraception in Kentucky pharmacies and has 
determined the relative importance of those factors. This thesis has also provided 
previously unavailable data and analysis which may be used to support future research on 
access to EC and public health interventions within Kentucky and beyond. It has 
provided evidence of the existence of greater barriers to EC access in Kentucky’s rural 
pharmacies. It has demonstrated that among the sampled pharmacies, the private 
ownership of a pharmacy was more determinative of likelihood of carrying EC that its 
rural location and has suggested this as an avenue of further inquiry. Lastly, this thesis 
has provided recommendations which, if implemented, will increase access to and the 
effective use of over-the-counter EC. In so doing, this thesis has not only substantively 
contributed to the literature on adolescent Emergency Contraception but has contributed 
to fulfilling the responsibility of Public Health to promote the reproductive health of all 
individuals and, specifically, to advocate for those least empowered to advocate for their 




















Appendix I: Flow Chart of Survey Instrument 
 
The following chart is designed to outline the flow of conversation during the semi-
structured interviews. The green arrows indicate “yes answers; the red arrows indicate 
“no” answers; and black arrows illustrate the conversational flow when the question will 




































Okay. Do you carry the 




would have it? 
Call end 
Can I get it now? 
Do I need a 
prescription? 
Okay, so I’m 15. Do I 
need to bring my mom 
or someone older…? 
How long after sex 
will it work? 
Is this the same like 
going and getting 
an abortion? 
Where can I find it 
in your store? 
How much is it? 
So are you the 
pharmacist or a tech 
or something? 



















































Correctly Stated Recommended Timeframe? 




















Average Perceived Discomfort Score 










Average Perceived Judgemental Score 






Average Perceived Unhelpful Score 











Average Perceived Negative Attitude Score 






Average Overall EC Knowledge Correct 
























































































Average Perceived Discomfort: Range 0-5 






Average Perceived Negative Attitude: Range 0-5 
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